Suche senden
Hochladen
2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
•
1 gefällt mir
•
228 views
Chuchai Sornchumni
Folgen
ชวนกันตรวจคัดกรองมะเร็งปากมดลูกเพื่อสุขภาวะของชาติ
Weniger lesen
Mehr lesen
Gesundheitswesen
Melden
Teilen
Melden
Teilen
1 von 19
Jetzt herunterladen
Downloaden Sie, um offline zu lesen
Empfohlen
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
SAKANAN ANANTASOOK
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
143.irritable bowel syndrome (guideline 2012)
143.irritable bowel syndrome (guideline 2012)
Aimmary
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg กรดไหลย้อนในเด็ก
Cpg กรดไหลย้อนในเด็ก
Utai Sukviwatsirikul
Cpg childhood obstructive sleep apnea
Cpg childhood obstructive sleep apnea
Utai Sukviwatsirikul
Correct English:9789740326281
Correct English:9789740326281
CUPress
宋代《演雅》诗研究
宋代《演雅》诗研究
sugeladi
Empfohlen
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
TSMT Journal03 (วารสาร สควค. ฉบับที่ 3)
SAKANAN ANANTASOOK
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
143.irritable bowel syndrome (guideline 2012)
143.irritable bowel syndrome (guideline 2012)
Aimmary
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg กรดไหลย้อนในเด็ก
Cpg กรดไหลย้อนในเด็ก
Utai Sukviwatsirikul
Cpg childhood obstructive sleep apnea
Cpg childhood obstructive sleep apnea
Utai Sukviwatsirikul
Correct English:9789740326281
Correct English:9789740326281
CUPress
宋代《演雅》诗研究
宋代《演雅》诗研究
sugeladi
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
CUPress
รายงานประจำปี 2548
รายงานประจำปี 2548
L.P.N. Development PCL.
Chandrayaanam
Chandrayaanam
Balu Bold
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNB Group
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNB Group
Rbi banking
Rbi banking
Chand Rook
Ph10 pa-004
Ph10 pa-004
DARSRADAR
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Eneutron
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
Raja Segaran
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Eneutron
Vro model paper
Vro model paper
krishna_t
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
bansi default
Code of sales PReMA 2010
Code of sales PReMA 2010
Utai Sukviwatsirikul
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Abousalimata
Ph10 pa-003
Ph10 pa-003
DARSRADAR
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNB Group
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
DMS Library
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Utai Sukviwatsirikul
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Weitere ähnliche Inhalte
Was ist angesagt?
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
CUPress
รายงานประจำปี 2548
รายงานประจำปี 2548
L.P.N. Development PCL.
Chandrayaanam
Chandrayaanam
Balu Bold
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNB Group
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNB Group
Rbi banking
Rbi banking
Chand Rook
Ph10 pa-004
Ph10 pa-004
DARSRADAR
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Eneutron
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
Raja Segaran
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Eneutron
Vro model paper
Vro model paper
krishna_t
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
bansi default
Code of sales PReMA 2010
Code of sales PReMA 2010
Utai Sukviwatsirikul
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Abousalimata
Ph10 pa-003
Ph10 pa-003
DARSRADAR
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNB Group
Was ist angesagt?
(16)
Gram Eng Easy:9789740326366
Gram Eng Easy:9789740326366
รายงานประจำปี 2548
รายงานประจำปี 2548
Chandrayaanam
Chandrayaanam
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 11, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
QNBFS Daily Technical Trader Qatar - January 17, 2021 التحليل الفني اليومي لب...
Rbi banking
Rbi banking
Ph10 pa-004
Ph10 pa-004
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
IIT-JEE Mains 2017 Offline Previous Question Paper Set C
Vaakkiyam amaittal 2012
Vaakkiyam amaittal 2012
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
IIT-JEE Mains 2016 Offline Previous Question Paper Set E
Vro model paper
Vro model paper
Grama revenue paripalana_margadarshini
Grama revenue paripalana_margadarshini
Code of sales PReMA 2010
Code of sales PReMA 2010
Qawaa Id Al Mouslaa
Qawaa Id Al Mouslaa
Ph10 pa-003
Ph10 pa-003
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
QNBFS Daily Technical Trader Qatar - December 28, 2020 التحليل الفني اليومي ل...
Ähnlich wie 2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
Utai Sukviwatsirikul
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
DMS Library
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Utai Sukviwatsirikul
Cough guideline 2016
Cough guideline 2016
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Utai Sukviwatsirikul
Guideline irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
Utai Sukviwatsirikul
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
Utai Sukviwatsirikul
แนวทางรักษา stroke-fast-track 2007
แนวทางรักษา stroke-fast-track 2007
Utai Sukviwatsirikul
Chocolate
Chocolate
tabrizandme
Hafezipoor
Hafezipoor
guest74b16
Ar To Eng General Sample
Ar To Eng General Sample
guest719aad
d
d
guest0b9544
7secret
7secret
paown
مقدمه ای بر داده کاوی و اکتشاف دانش
مقدمه ای بر داده کاوی و اکتشاف دانش
dataminers.ir
5s
5s
ebrahim bagheri
The President’s Speech in Cairo: A New Beginning - Dari
The President’s Speech in Cairo: A New Beginning - Dari
Obama White House
modiriatbazargani
modiriatbazargani
guesta8c13
سيكولوجيه اللغه والمرض العقلى
سيكولوجيه اللغه والمرض العقلى
mshary mshary
الکرد والحمدانیون
الکرد والحمدانیون
Chalak Muhamad
Ähnlich wie 2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
(20)
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ พ.ศ. 2560
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
โรคหลอดเลือดสมองแตกสำหรับแพทย์ : P1 39
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
แนวทางการวินิจฉัยและรักษาโรคหืดในประเทศไทย สำหรับผู้ใหญ่ 2559
Cough guideline 2016
Cough guideline 2016
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Cpg for irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
Guideline irritable bowel syndrome 2012
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
คำแนะนำเกี่ยวกับโรคลำไส้แปรปรวน Ibs สำหรับแพทย์ทั่วไป (แนวทางเวชปฏิบัติ 2012)
แนวทางรักษา stroke-fast-track 2007
แนวทางรักษา stroke-fast-track 2007
Chocolate
Chocolate
Hafezipoor
Hafezipoor
Ar To Eng General Sample
Ar To Eng General Sample
d
d
7secret
7secret
مقدمه ای بر داده کاوی و اکتشاف دانش
مقدمه ای بر داده کاوی و اکتشاف دانش
5s
5s
The President’s Speech in Cairo: A New Beginning - Dari
The President’s Speech in Cairo: A New Beginning - Dari
modiriatbazargani
modiriatbazargani
سيكولوجيه اللغه والمرض العقلى
سيكولوجيه اللغه والمرض العقلى
الکرد والحمدانیون
الکرد والحمدانیون
Mehr von Chuchai Sornchumni
Precision medicine
Precision medicine
Chuchai Sornchumni
Priorities with PHC (chuchai jun2018)
Priorities with PHC (chuchai jun2018)
Chuchai Sornchumni
UHC lesson learn Thailand
UHC lesson learn Thailand
Chuchai Sornchumni
ระบบประกันการดูแลระยะยาว
ระบบประกันการดูแลระยะยาว
Chuchai Sornchumni
New perspectives on global healthspending UHC
New perspectives on global healthspending UHC
Chuchai Sornchumni
2561จอร์แดนบันทึกการเดินทาง
2561จอร์แดนบันทึกการเดินทาง
Chuchai Sornchumni
Introduction2 publichealth
Introduction2 publichealth
Chuchai Sornchumni
Public finance
Public finance
Chuchai Sornchumni
DiseaseMntChrRespSyst
DiseaseMntChrRespSyst
Chuchai Sornchumni
ChronicDzMntRespiratoryIllness
ChronicDzMntRespiratoryIllness
Chuchai Sornchumni
Thailand situational assessment2015
Thailand situational assessment2015
Chuchai Sornchumni
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
Chuchai Sornchumni
Welfare analysis for uhc
Welfare analysis for uhc
Chuchai Sornchumni
พระปกเกล้า20170527
พระปกเกล้า20170527
Chuchai Sornchumni
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
Chuchai Sornchumni
นักโภชนาการนักกำหนดอาหาร2017
นักโภชนาการนักกำหนดอาหาร2017
Chuchai Sornchumni
Final annual report nhso 2559
Final annual report nhso 2559
Chuchai Sornchumni
ช่วงนี้ มีประเด็น
ช่วงนี้ มีประเด็น
Chuchai Sornchumni
สาธารณสุขเชิงรุก
สาธารณสุขเชิงรุก
Chuchai Sornchumni
Ncd nhes v_2016
Ncd nhes v_2016
Chuchai Sornchumni
Mehr von Chuchai Sornchumni
(20)
Precision medicine
Precision medicine
Priorities with PHC (chuchai jun2018)
Priorities with PHC (chuchai jun2018)
UHC lesson learn Thailand
UHC lesson learn Thailand
ระบบประกันการดูแลระยะยาว
ระบบประกันการดูแลระยะยาว
New perspectives on global healthspending UHC
New perspectives on global healthspending UHC
2561จอร์แดนบันทึกการเดินทาง
2561จอร์แดนบันทึกการเดินทาง
Introduction2 publichealth
Introduction2 publichealth
Public finance
Public finance
DiseaseMntChrRespSyst
DiseaseMntChrRespSyst
ChronicDzMntRespiratoryIllness
ChronicDzMntRespiratoryIllness
Thailand situational assessment2015
Thailand situational assessment2015
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
ทบทวนประสบการณ์ Universal Health Coverage 11 ประเทศ
Welfare analysis for uhc
Welfare analysis for uhc
พระปกเกล้า20170527
พระปกเกล้า20170527
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
ร่วมจ่ายทบทวนประสบการณ์ระบบสุขภาพอเมริกา
นักโภชนาการนักกำหนดอาหาร2017
นักโภชนาการนักกำหนดอาหาร2017
Final annual report nhso 2559
Final annual report nhso 2559
ช่วงนี้ มีประเด็น
ช่วงนี้ มีประเด็น
สาธารณสุขเชิงรุก
สาธารณสุขเชิงรุก
Ncd nhes v_2016
Ncd nhes v_2016
Kürzlich hochgeladen
Budhwar Peth ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready...
Budhwar Peth ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready...
tanu pandey
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
mahaiklolahd
Call Girls Service Chandigarh Sexy Video ❤️🍑 8511114078 👄🫦 Independent Escort...
Call Girls Service Chandigarh Sexy Video ❤️🍑 8511114078 👄🫦 Independent Escort...
Sheetaleventcompany
Rishikesh Call Girls Service 6398383382 Real Russian Girls Looking Models
Rishikesh Call Girls Service 6398383382 Real Russian Girls Looking Models
Rupali Sharma
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Sheetaleventcompany
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Sheetaleventcompany
Call Girl in Indore 8827247818 {Low Price}👉 Meghna Indore Call Girls * DXZ...
Call Girl in Indore 8827247818 {Low Price}👉 Meghna Indore Call Girls * DXZ...
mahaiklolahd
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Ahmedabad Call Girls
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
Sheetaleventcompany
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
mahaiklolahd
👉Bangalore Call Girl Service👉📞 7304373326 👉📞 Just📲 Call Rajveer Call Girls Se...
👉Bangalore Call Girl Service👉📞 7304373326 👉📞 Just📲 Call Rajveer Call Girls Se...
Sheetaleventcompany
Kochi call girls Mallu escort girls available 7877702510
Kochi call girls Mallu escort girls available 7877702510
Vipesco
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
Ahmedabad Call Girls
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
only4webmaster01
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
India Call Girls
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Sheetaleventcompany
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Sheetaleventcompany
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Ahmedabad Call Girls
9316020077📞Majorda Beach Call Girls Numbers, Call Girls Whatsapp Numbers Ma...
9316020077📞Majorda Beach Call Girls Numbers, Call Girls Whatsapp Numbers Ma...
Goa cutee sexy top girl
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
Sheetaleventcompany
Kürzlich hochgeladen
(20)
Budhwar Peth ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready...
Budhwar Peth ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girls Service Chandigarh Sexy Video ❤️🍑 8511114078 👄🫦 Independent Escort...
Call Girls Service Chandigarh Sexy Video ❤️🍑 8511114078 👄🫦 Independent Escort...
Rishikesh Call Girls Service 6398383382 Real Russian Girls Looking Models
Rishikesh Call Girls Service 6398383382 Real Russian Girls Looking Models
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Call Girl in Indore 8827247818 {Low Price}👉 Meghna Indore Call Girls * DXZ...
Call Girl in Indore 8827247818 {Low Price}👉 Meghna Indore Call Girls * DXZ...
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
👉Bangalore Call Girl Service👉📞 7304373326 👉📞 Just📲 Call Rajveer Call Girls Se...
👉Bangalore Call Girl Service👉📞 7304373326 👉📞 Just📲 Call Rajveer Call Girls Se...
Kochi call girls Mallu escort girls available 7877702510
Kochi call girls Mallu escort girls available 7877702510
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
9316020077📞Majorda Beach Call Girls Numbers, Call Girls Whatsapp Numbers Ma...
9316020077📞Majorda Beach Call Girls Numbers, Call Girls Whatsapp Numbers Ma...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Jiya 📲🔝8868886958🔝Call Girls In Chandigarh No...
2012 sirisamut j health sc_evaluation of outcomes and determinants of cervical cancer screening in th_2005-9
1.
«“√ “√«‘™“°“√ “Π“√≥
ÿ¢ ªïΣ’Ë ÚÒ ©∫—∫Σ’Ë Û æƒ…¿“§¡ - ¡‘∂ÿπ“¬π Úııı Journal of Health Science Vol. 21 No. 3 May - June 2012 Original Article π‘æπΠåμâπ©∫—∫ Π’√– »‘√‘ ¡ÿ¥* √—°¡≥’ ∫ÿμ√™π* ‡™‘≠¢«—≠ ¿ÿ™¨ß§å* À—™™“ »√’ª≈—Ë߆ π—¬π“ ª√–¥‘…∞å ‘ΣΠ‘°√* ≈’Ë≈’ Õ‘ß»√’ «à“߇ ‡πμ‘ ÿ¢ ¡∫Ÿ√≥å§ »√’‡æÁ≠ μ—π쑇« * ¬» μ’√–«—≤π“ππΣå* *‚§√ß°“√ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈–π‚¬∫“¬¥â“π ÿ¢¿“æ °√–Σ√«ß “Π“√≥ ÿ¢ †Àπ૬√–∫“¥«‘Σ¬“ §≥–·æΣ¬»“ μ√å ¡À“«‘Σ¬“≈—¬ ߢ≈“π§√‘πΣ√å ‡¿“§«‘™“ ∂‘μ‘ §≥–«‘Σ¬“»“ μ√å ¡À“«‘Σ¬“≈—¬‡°…μ√»“ μ√å §¿“§«‘™“‡¿ —™°√√¡ §≥–‡¿ —™»“ μ√å ¡À“«‘Σ¬“≈—¬¡À‘¥≈ 538 °“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap Smear) ·≈–«’‰Õ‡Õ (Visual Inspection with Acetic Acid) „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ∫Σ§—¥¬àÕ ¡–‡√Áߪ“°¡¥≈Ÿ°‡ªìπªí≠À“ “Π“√≥ ÿ¢Σ’Ë ”§—≠¢Õߪ√–‡Σ»‰Σ¬ Σ—ÈßΣ’Ë¡’∫√‘°“√μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“·≈– √—°…“§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–‡√‘Ë¡μâπ¡“π“π°«à“ 40 ªï ·μàÕ—μ√“°“√μ√«®§—¥°√Õß°Á¬—ßμË”¡“° μ—Èß·μàæ.». 2548 ‡ªìπμâπ¡“ √—∞∫“≈¡’π‚¬∫“¬≈¥°“√ªí≠À“¥—ß°≈à“« ‚¥¬¥”‡π‘π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ °“√»÷°…“π’È¡’«—μ∂ÿª√– ߧå‡æ◊ËÕª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï¢Õß‚§√ß°“√oe ·≈– ªí®®—¬Σ’ˇ°’ˬ«¢âÕß „πΣÿ°¿“§√«¡ 12 ®—ßÀ«—¥ μ—Èß·μà‡¥◊Õπ°—𬓬π 2552 ∂÷߇¥◊Õπ情¿“§¡ 2553 ´÷Ëߪ√–°Õ∫¥â«¬ 1) °“√ ”√«®ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√°≈ÿࡇªÑ“À¡“¬ ®“°À≠‘ßÕ“¬ÿ 30-60 ªï ®”π«π 4,640 §π ‡°Á∫¢âÕ¡Ÿ≈¥â«¬ °“√ —¡¿“…≥å ·≈– 2) °“√ ”√«®ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√·≈–√–∫∫∫√‘°“√‚¥¬ àß·∫∫ Õ∫∂“¡Σ“߉ª√…≥’¬å ‰ª¬—ߺŸâ„Àâ∫√‘°“√Σ—ÈßÀ¡¥®”π«π 3,526 §π «‘‡§√“–Àå¢âÕ¡Ÿ≈‚¥¬«‘Π’Σ“ß ∂‘쑇™‘ßæ√√≥“·≈– ∂‘μ‘æÀÿ‚≈®‘ μ‘° ‡æ◊ËÕ«‘‡§√“–Àåªí®®—¬Σ’Ë¡’§«“¡ —¡æ—πΠå º≈°“√»÷°…“„πÀ≠‘ß°≈ÿࡺŸâ√—∫∫√‘°“√ (Õ—μ√“§«“¡√à«¡¡◊Õ 97%) æ∫Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“° ¡¥≈Ÿ°„π™à«ß æ.». 2548-2552 ‡Σà“°—∫√âÕ¬≈– 68 ‚¥¬‡æ‘Ë¡¢÷ÈπÕ¬à“ß™—¥‡®π„πæ.». 2551-2552 à«π„À≠àμ√«® ¥â«¬«‘Π’·ªª ‡¡’¬√å (88%) à«πΣ’Ëμ√«®¥â«¬«‘Π’«’‰Õ‡Õ (7%) §√÷ËßÀπ÷Ë߉ªμ√«®§—¥°√ÕßΣ’Ë ∂“π’Õπ“¡—¬ ªí®®—¬ à߇ √‘¡„Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õ߉¥â·°à Õ“¬ÿ√–À«à“ß 40-50 ªï Õ“»—¬„π‡¢μ™π∫Σ ª√–°Õ∫Õ“™’懰…μ√°√√¡ ‡§¬μ—Èߧ√√¿å ‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√°“√μ√«®§—¥°√Õß ¡’Σ—»π§μ‘‡™‘ß∫«°μàÕ°“√√—∫ ¢âÕ¡Ÿ≈®“° ◊ËÕ “Π“√≥–·≈–‰¥â√—∫°“√°√–μÿâπ®“° ¡“™‘°„π§√Õ∫§√—« „π¢≥–Σ’Ëªí®®—¬Σ’Ë¡’§«“¡ —¡æ—πΠå°—∫ °“√ªØ‘‡ Π°“√√—∫∫√‘°“√ ‰¥â·°à °“√‡ªìπ¡ÿ ≈‘¡ ¡’ª√–«—μ‘ Ÿ∫∫ÿÀ√’Ë §«“¡‡¢â“„®º‘¥«à“À≈—ßμ√«®·≈⫉¡àæ∫§«“¡ º‘¥ª√°μ‘°Á‰¡àμâÕß¡“μ√«®´È”Õ’° ·≈–‡¢â“„®º‘¥«à“¡’°“√„Àâ∫√‘°“√μ√«®§—¥°√Õ߇©æ“–„π‚√ß欓∫“≈‡Σà“π—Èπ
2.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ”À√—∫ºŸâ„Àâ∫√‘°“√ (Õ—μ√“μÕ∫°≈—∫ 55%) à«π„À≠à‡ÀÁπ«à“ªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¡’§«“¡ ”§—≠·≈–°“√ μ√«®§—¥°√Õ߇ªìπ«‘Π’Σ’Ë®–™à«¬≈¥ªí≠À“π’ȉ¥â √«¡Σ—È߇ÀÁπ«à“ªí®®—¬π”‡¢â“ (‡™àπ ∫ÿ§≈“°√ °“√®—¥ √√ß∫ª√–¡“≥ ·≈–‡§√◊ËÕß¡◊Õ/Õÿª°√≥å ‡ªìπμâπ) °“√Õ∫√¡∫ÿ§≈“°√ °“√øóôπøŸ§«“¡√Ÿâ ·≈–°“√§«∫§ÿ¡§ÿ≥¿“欗߉¡à‡æ’¬ßæÕ ¢âÕ§âπæ∫¥—ß°≈à“«· ¥ß„Àâ‡ÀÁπ«à“ §«√®—¥∫√‘°“√‡™‘ß√ÿ°„πÀ≠‘ß°≈ÿà¡Σ’Ë¡’Õ—μ√“√—∫∫√‘°“√μË” ‡æ‘Ë¡«‘Π’·≈– ™àÕßΣ“ß°“√ ◊ËÕ “√„Àâ®”‡æ“–°—∫°≈ÿࡇªÑ“À¡“¬‡æ◊ËÕ à߇ √‘¡§«“¡√Ÿâ·≈–Σ—»§μ‘Σ’Ë¥’ Õ’°Σ—Èߧ«√°”Àπ¥π‚¬∫“¬Σ’Ë ™—¥‡®π‡√◊ËÕß°≈ÿà¡Õ“¬ÿ «‘Π’°“√μ√«® °“√®—¥ √√ß∫ª√–¡“≥ ·≈–‡æ‘Ë¡°“√ π—∫ πÿπªí®®—¬π”‡¢â“ ‡™à𠇧√◊ËÕß¡◊Õ Õÿª°√≥å √–∫∫∫—πΣ÷°·≈–√“¬ß“π¢âÕ¡Ÿ≈ Σ’Ë‡Õ◊ÈÕ·≈–‡ªìπ·√ß®Ÿß„®μàÕ°“√„Àâ∫√‘°“√¢ÕߺŸâªØ‘∫—μ‘ß“π §” ”§—≠: ¡–‡√Áߪ“°¡¥≈Ÿ°, °“√μ√«®§—¥°√Õß, °“√ª√–‡¡‘πº≈‚§√ß°“√ ∫Σπ” ¡–‡√Áߪ“°¡¥≈Ÿ°‡ªìπªí≠À“¥â“π “Π“√≥ ÿ¢Σ’Ë ”§—≠¢ÕßÀ≈“¬ª√–‡Σ»Σ—Ë«‚≈°(1) ª√–‡Σ»Σ’Ëæ—≤π“ ·≈â«æ∫Õÿ∫—μ‘°“√¢Õß‚√§π’ȧàÕπ¢â“ßμË” (4-11 §πμàÕ · πª√–™“°√À≠‘ß) „π¢≥–Σ’Ëª√–‡Σ»°”≈—ßæ—≤π“ ·≈–¥âÕ¬æ—≤π“æ∫Õ—μ√“Õÿ∫—μ‘°“√ Ÿß (20-55 §πμàÕ · πª√–™“°√À≠‘ß)(2) ªí®®—¬Σ’ËΣ”„À⇰‘¥§«“¡·μ°μà“ß ¥—ß°≈à“« ‰¥â·°à °“√Σ’Ëª√–‡Σ»Σ’Ëæ—≤π“·≈â«¡’‚§√ß°“√ μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“·≈–√—°…“ºŸâªÉ«¬„π√–¬–°àÕ𠇪ìπ¡–‡√ÁßΣ’Ë¡’ª√– ‘ΣΠ‘¿“æ·≈–§«“¡§√Õ∫§≈ÿ¡°≈ÿà¡ ‡ªÑ“À¡“¬ Ÿß°«à“ª√–‡Σ»Σ’Ëæ—≤π“πâÕ¬°«à“(3) „πª√–‡Σ»‰Σ¬ ¡–‡√Áߪ“°¡¥≈Ÿ°¡’¢π“¥¢Õߪí≠À“ Õ—π¥—∫μâπ Ê ¢Õß¡–‡√ÁßΣ’Ëæ∫„π‡æ»À≠‘ß ‚¥¬ æ.». 2546 ¡’Õÿ∫—μ‘°“√‡Σà“°—∫ 18.1 μàÕ· πª√–™“°√À≠‘ß ´÷Ëß„πªï ‡¥’¬«°—πæ∫®”π«πºŸâªÉ«¬√“¬„À¡àª√–¡“≥ 6,300 √“¬(4) °√–Σ√«ß “Π“√≥ ÿ¢„Àâ∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap smear) ¡“°«à“ 40 ªï μàÕ¡“„π æ.».2543 ‡√‘Ë¡„Àâ∫√‘°“√μ√«®¥â«¬«‘Π’«’‰Õ‡Õ (Visual inspection with Acetic Acid, VIA) º≈®“° °“√¥”‡π‘πß“πΣ’Ëºà“π¡“æ∫«à“§«“¡§√Õ∫§≈ÿ¡°“√‡¢â“ √—∫∫√‘°“√À≠‘ß°≈ÿࡇªÑ“À¡“¬¬—߉¡à‡ªìπ‰ªμ“¡ ‡ªÑ“ª√– ߧåΣ’Ë°”Àπ¥‰«â ¥—ßπ—Èπ„π æ.».2548 ®÷߇√‘Ë¡ ¥”‡π‘π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥ ¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ ‡ªìπ‚§√ß°“√√–¬– 5 ªï ‚¥¬¡’«—μ∂ÿª√– ߧå‡æ◊ËÕ„Àâª√–™“™π¡’§«“¡√Ÿâ‡√◊ËÕß¡–‡√Áß «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ª“°¡¥≈Ÿ°·≈–„À⧫“¡ ”§—≠°—∫°“√μ√«®§—¥°√Õß „Àâ ∫√‘°“√μ√«®§—¥°√Õ߇æ◊ËÕ§âπÀ“§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å ¡–‡√Áß„π√–¬–‡√‘Ë¡μâπæ√âÕ¡Σ—Èß π—∫ πÿπ√–∫∫ àßμàÕ «‘π‘®©—¬·≈–√—°…“‚√§¡–‡√Áߪ“°¡¥≈Ÿ°Õ¬à“ß¡’ª√– ‘ΣΠ‘- ¿“æ ·°àÀ≠‘ß°≈ÿࡇªÑ“À¡“¬„Àâ§√Õ∫§≈ÿ¡Σÿ°æ◊ÈπΣ’Ë‚¥¬ À≠‘ß‰Σ¬Σ’Ë¡’Õ“¬ÿ 35 40 45 50 55 ·≈– 60 ªï „À≥â √—∫∫√‘°“√μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å„πΣÿ°®—ßÀ«—¥ Σ—Ë«ª√–‡Σ» πÕ°®“°π’È ∂“π欓∫“≈„π 15 ®—ßÀ«—¥Σ’Ë æ√âÕ¡·≈– ¡—§√„®„Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ§«∫§Ÿà°—∫«‘Π’ ·ªª ‡¡’¬√å ‚¥¬„™â«‘Π’«’‰Õ‡Õ°—∫ºŸâΣ’Ë¡’Õ“¬ÿ 30-44 ªï (¬°‡«âπÀ≠‘ßÕ“¬ÿ 35 ·≈– 40 ªï) ·≈–„™â«‘Π’·ªª ‡¡’¬√å °—∫ºŸâΣ’Ë¡’Õ“¬ÿ 35 40 45 50 55 ·≈– 60 ªï Σ—Èßπ’È°√¡ °“√·æΣ¬å·≈–°√¡Õπ“¡—¬√—∫º‘¥™Õ∫√–∫∫°“√μ√«® §—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å·≈– «‘Π’«’‰Õ‡Õμ“¡≈”¥—∫ ‚¥¬ §√Õ∫§≈ÿ¡Σ—Èߥâ“π«‘™“°“√ °“√¥”‡π‘πß“π ·≈–√–∫∫ ¢âÕ¡Ÿ≈ “√ π‡Σ»(5) ¡’√“¬ß“πº≈°“√¥”‡π‘πß“π„π™à«ß æ.». 2550 ·√°æ∫Õ—μ√“°“√μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å §√Õ∫§≈ÿ¡°≈ÿࡇªÑ“À¡“¬¢Õß‚§√ß°“√ª√–¡“≥√âÕ¬≈– 50(6) Õ¬à“߉√°Áμ“¡®“°∞“π¢âÕ¡Ÿ≈Σ–‡∫’¬π§—¥°√Õß Pap Registry ´÷Ë߇°Á∫Σ–‡∫’¬π§—¥°√Õß«‘Π’·ªª ‡¡’¬√å·≈– CPIStm ´÷Ë߇°Á∫Σ–‡∫’¬π§—¥°√Õß«‘Π’«’‰Õ‡Õ‚¥¬§”π«≥ ®“°∞“πª√–™“°√À≠‘ß°≈ÿࡇªÑ“À¡“¬Σ—Ë«ª√–‡Σ» æ∫ Õ—μ√“§√Õ∫§≈ÿ¡Σ’ËμË”°«à“¡“° °≈à“«§◊Õ «‘Π’·ªª ‡¡’¬√å √âÕ¬≈– 8.8 ·≈–«‘Π’«’‰Õ‡Õ√âÕ¬≈– 18.8(7) ıÛ˘
3.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°Õ“®‡°‘¥ ®“°À≈“¬ªí®®—¬Σ—ÈßΣ’Ë‡°’ˬ«°—∫À≠‘ß°≈ÿࡇªÑ“À¡“¬Σ’ˇªìπ ºŸâ√—∫∫√‘°“√ ºŸâ„Àâ∫√‘°“√ √–∫∫∫√‘°“√ ·≈–√–∫∫ π—∫ πÿπ ¥—ßπ—Èπ°“√»÷°…“π’È ®÷ß¡’«—μ∂ÿª√– ߧå‡æ◊ËÕª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°- ¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ ‡æ◊ËÕπ” ¢âÕ¡Ÿ≈ª√–°Õ∫„π°“√æ‘®“√≥“ª√—∫°≈¬ÿΣΠå·≈–«‘Π’°“√ ªØ‘∫—μ‘ß“π„Àâ¡’§«“¡‡À¡“– ¡ ´÷Ëß®–™à«¬„Àâ∫√√≈ÿ‡ªÑ“- À¡“¬¢Õß°“√ªÑÕß°—π·≈–§«∫§ÿ¡¡–‡√Áߪ“°¡¥≈Ÿ°μàÕ‰ª «‘Π’°“√»÷°…“ °“√»÷°…“π’ȇªìπ°“√«‘®—¬‡™‘ß ”√«® ¥”‡π‘π°“√μ—Èß ·μà‡¥◊Õπ°—𬓬π æ.».2552 ∂÷߇¥◊Õπ情¿“§¡ æ.». 2553 ·∫àßÕÕ°‡ªìπ 2 à«π ‰¥â·°à °“√»÷°…“„π°≈ÿà¡ ºŸâ√—∫∫√‘°“√ ·≈–°“√»÷°…“„π°≈ÿࡺŸâ„Àâ∫√‘°“√ ´÷Ëß¡’ «—μ∂ÿª√– ߧ凩擖 ¥—ßπ’È 1. ‡æ◊ËÕª√–‡¡‘πÕ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ° ·≈–»÷°…“ªí®®—¬®“°°≈ÿࡺŸâ√—∫∫√‘°“√ Σ’Ë¡’º≈ μàÕ°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕߺŸâÀ≠‘ß°≈ÿࡇªÑ“- À¡“¬Õ“¬ÿ 30-60 ªï 2. ‡æ◊ËÕ»÷°…“ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ ºŸâ∫√‘À“√ √–∫∫∫√‘°“√·≈–√–∫∫ π—∫ πÿπÕ◊Ëπ Ê Σ’Ë¡’º≈μàÕ°“√ ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕßÀ≠‘ß °≈ÿࡇªÑ“À¡“¬ æ◊ÈπΣ’Ë»÷°…“: √«¡ 12 ®—ßÀ«—¥ ‰¥â·°à ®—ßÀ«—¥‡™’¬ß„À¡à ·æ√à æ‘…≥ÿ‚≈° π§√æπ¡ √âÕ¬‡ÕÁ¥ π§√√“™ ’¡“ √–·°â« π§√ª∞¡ ‡æ™√∫ÿ√’ ™ÿ¡æ√ ߢ≈“ ·≈–π§√»√’Π√√¡√“™ ¡’·π«Σ“߇≈◊Õ°®—ßÀ«—¥μ—«Õ¬à“ߥ⫬°“√ ÿà¡Õ¬à“߇ªìπ √–∫∫„π 4 ™—Èπ¿Ÿ¡‘ (stratified four-stage sampling) ‚¥¬·∫àßæ◊ÈπΣ’Ëª√–‡Σ»‰Σ¬‡ªìπ 4 ¿“§ ‰¥â·°à ¿“§‡Àπ◊Õ ¿“§μ–«—πÕÕ°‡©’¬ß‡Àπ◊Õ ¿“§°≈“ß/μ–«—πÕÕ°/μ–«—πμ° ·≈–¿“§„μâ ·≈–·∫àß®—ßÀ«—¥„π·μà≈–¿“§‡ªìπ 3 °≈ÿà¡ μ“¡≈—°…≥–æ◊ÈπΣ’Ë‡ªìπ¢π“¥„À≠à °≈“ß·≈–¢π“¥‡≈Á° ·≈– ÿࡇ≈◊Õ°μ“¡≈—°…≥–æ◊ÈπΣ’Ë§≈–°—π¿“§≈– 3 ®—ßÀ«—¥ ‚¥¬·μà≈–¿“§®– ÿà¡®—ßÀ«—¥Õ¬à“ßßà“¬ (simple random sampling, SRS) Σ’Ë¡’°“√μ√«®§—¥°√ÕßΣ—Èß 2 «‘Π’§◊Õ «’‰Õ‡Õ°—∫«‘Π’·ªª ‡¡’¬√å¡“ 1 ®—ßÀ«—¥ ·≈– ÿà¡®—ßÀ«—¥ Õ¬à“ßßà“¬ (SRS) Σ’Ëμ√«®§—¥°√Õ߇©æ“–«‘Π’·ªª ‡¡’¬√å¡“ 2 ®—ßÀ«—¥ à«πΣ’Ë 1 °“√»÷°…“„π°≈ÿࡺŸâ√—∫∫√‘°“√ 1) √Ÿª·∫∫°“√»÷°…“ ‡ªìπ°“√ ”√«®¿“§μ—¥¢«“ß (cross-sectional survey) 2) ª√–™“°√·≈–°≈ÿà¡μ—«Õ¬à“ß ª√–™“°√ §◊Õ ºŸâÀ≠‘ß‰Σ¬Õ“¬ÿ 30-60 ªï ´÷Ë߇ªìπ°≈ÿࡇªÑ“À¡“¬ ‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’ ·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - 2552 °≈ÿà¡μ—«Õ¬à“ß §◊Õ ºŸâÀ≠‘ß‰Σ¬Õ“¬ÿ 30-60 ªïΣ’Ë¡’√“¬™◊ËÕ„πΣ–‡∫’¬π°“√ μ√«®§—¥°√ÕߢÕß ∂“π欓∫“≈„πæ◊ÈπΣ’Ë»÷°…“„πæ.». 2548 - 2552 3) ¢π“¥μ—«Õ¬à“ß·≈–°“√ ÿà¡μ—«Õ¬à“ß °“√§”π«≥ ¢π“¥μ—«Õ¬à“ß„™â Ÿμ√ ‚¥¬Σ’Ë 1.96 (§à“§ßΣ’ËΣ’Ë√–¥—∫§«“¡‡™◊ËÕ¡—Ëπ 95%) N = ®”π«πª√–™“°√ºŸâÀ≠‘߇ªÑ“À¡“¬Õ“¬ÿ 30- 60 ªïΣ—Ë«ª√–‡Σ» σ = §à“§«“¡·ª√ª√«π¢Õß°“√ ª√–¡“≥§à“ª√–™“°√ ´÷ËßΣ’Ëºà“π¡“‰¡à¡’°“√»÷°…“Σ’Ë “¡“√∂√–∫ÿ‰¥â«à“®”π«πÀ≠‘ß°≈ÿࡇªÑ“À¡“¬Õ“¬ÿ 30-60 ªï„π√–¥—∫¿“§À√◊Õª√–‡Σ»π—Èπ¡’§«“¡·ª√ª√«π¡“° πâÕ¬‡æ’¬ß„¥ °“√»÷°…“§√—Èßπ’È®÷ß°”Àπ¥„Àâ‡Σà“°—∫ 1 ·≈– ε = §«“¡º‘¥æ≈“¥À√◊Õ§«“¡§≈“¥‡§≈◊ËÕπΣ’Ë¬Õ¡„À⇰‘¥¢÷È𠉥â„πß“π«‘®—¬ ‡Σà“°—∫√âÕ¬≈– 4 ‚¥¬°”Àπ¥Õ—μ√“°“√ °“√‰¡à¬‘π¥’„Àâ¢âÕ¡Ÿ≈‡Σà“°—∫√âÕ¬≈– 20 ‰¥â¢π“¥μ—«Õ¬à“ß Σ—Èß ‘ÈπΣ—Èß ‘Èπ 4,640 §π „π™—Èπ¿Ÿ¡‘Σ’Ë 3 ÿࡇ≈◊Õ°μ“¡ —¥ à«π®”π«π™ÿ¡™πÀ√◊ÕÀ¡Ÿà∫â“π„πÕ”‡¿Õμ—«Õ¬à“ßπ—Èπ Ê (probability proportional to size) ‰¥â®”π«π À¡Ÿà∫â“πÀ√◊Õ™ÿ¡™πΣ—Èß ‘Èπ 232 ·À≈àß „π™—Èπ¿Ÿ¡‘ ÿ¥Σ⓬ ÿࡇ≈◊Õ°°≈ÿà¡μ—«Õ¬à“ß„πæ◊ÈπΣ’ËÕ¬à“߇ªìπ√–∫∫ À¡Ÿà∫â“π À√◊Õ™ÿ¡™π≈– 20 §π¥â«¬μ“√“ß ÿà¡®“°Σ–‡∫’¬π°≈ÿà¡ 540 Journal of Health Science 2012 Vol. 21 No. 3
4.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ‡ªÑ“À¡“¬μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢Õß ∂“π 欓∫“≈Σ’Ë√—∫º‘¥™Õ∫ 4) ‡§√◊ËÕß¡◊Õ‡°Á∫¢âÕ¡Ÿ≈ ºŸâ«‘®—¬æ—≤π“·∫∫ —¡¿“…≥å(8) ‡æ◊ËÕ‡°Á∫¢âÕ¡Ÿ≈¥—ßπ’È 1) ≈—°…≥–¢âÕ¡Ÿ≈Σ—Ë«‰ª ‰¥â·°à ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘® ·≈– —ߧ¡ 2) ¢âÕ¡Ÿ≈¥â“πæƒμ‘°√√¡ ÿ¢¿“æ 3) °“√‰¥â √—∫¢à“« “√‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥ °√Õß 4) §«“¡√Ÿâ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß 5) Σ—»π§μ‘‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ μ√«®§—¥°√Õß 6) ª√–«—μ‘°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥ °√Õß„π√Õ∫ 5 ªïΣ’Ëºà“π¡“ 5) «‘Π’‡°Á∫¢âÕ¡Ÿ≈ ‡ªìπ°“√ —¡¿“…≥åμ—«μàÕμ—«°—∫ °≈ÿà¡μ—«Õ¬à“ß ‚¥¬‡™‘≠°≈ÿà¡μ—«Õ¬à“ßμ“¡√“¬™◊ËÕ ÿà¡¡“ ª√–™ÿ¡„π ∂“πΣ’Ë„°≈â∫â“𠇙àπ ∂“π’Õπ“¡—¬ »“≈“ °≈“ß∫â“π «—¥ ‚√߇√’¬π ‡ªìπμâπ π—°«‘®—¬Õà“π¢âÕ§”∂“¡ „Àâ°≈ÿà¡μ—«Õ¬à“ßøíß·≈–∫—πΣ÷°§”μÕ∫≈ß„π·∫∫ —¡¿“…≥å πÕ°®“°π’Èπ—°«‘®—¬‰¥â ÿà¡√“¬™◊ËÕ®“°Σ–‡∫’¬π°≈ÿࡇªÑ“- À¡“¬‡ªìπ 2 ∫—≠™’ À“° —¡¿“…≥å°≈ÿà¡μ—«Õ¬à“߉¡à§√∫ 20 §π „π∫—≠™’Σ’Ë 1 ‚¥¬æ‘®“√≥“°≈ÿà¡Õ“¬ÿΣ’Ë¢“¥À“¬‰ª„π ·μà≈–æ◊ÈπΣ’Ë ·≈–À“°‰¥â®”π«π°≈ÿà¡μ—«Õ¬à“߉¡à§√∫„π ∫—≠™’Σ’Ë 2 °Á∂◊Õ«à“‡ªìπÕ—π ‘Èπ ÿ¥ 6) °“√«‘‡§√“–Àå¢âÕ¡Ÿ≈ «‘‡§√“–Àå¢âÕ¡Ÿ≈¥â«¬ ‚ª√·°√¡ ”‡√Á®√Ÿª ¡’ ∂‘μ‘Σ’Ë„™â ¥—ßπ’È 1. ∂‘쑇™‘ßæ√√≥“ ‰¥â·°à §à“§«“¡∂’Ë √âÕ¬≈– —¥ à«π §à“‡©≈’ˬ·≈– à«π‡∫’ˬ߇∫π¡“μ√∞“π‡æ◊ËÕ ∫√√¬“¬≈—°…≥–Σ—Ë«‰ª ‡™àπ ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘®·≈– —ߧ¡ æƒμ‘°√√¡ ÿ¢¿“æ §«“¡√Ÿâ·≈–Σ—»π§μ‘‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ √—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ßμ—«Õ¬à“ß 2. ∂‘쑇™‘ß«‘‡§√“–Àå ‰¥â·°à ∂‘쑧«“¡∂¥∂Õ¬ ‚≈®‘ μ‘°‡™‘ßæÀÿ ‡æ◊ËÕæ‘ Ÿ®π姫“¡ —¡æ—πΠå¢Õßªí®®—¬μà“ßÊ μàÕ°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ßμ—«Õ¬à“ß ‰¥â §à“ adjusted odds ratio (ORadj) ·≈–™à«ß§«“¡‡™◊ËÕ ¡—ËπΣ’Ë 95% (95% confidence interval) ‚¥¬°”Àπ¥ √–¥—∫π—¬ ”§—≠Σ“ß ∂‘μ‘Σ’Ë 0.05 (p-value ≤ 0.05) «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û 3. ª√–¡“≥§à“¬Õ¥√«¡ª√–™“°√ ‡ªìπ°“√ §”π«≥§à“∂à«ßπÈ”Àπ—°‡æ◊ËÕª√–¡“≥°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°®“°°“√ ”√«®„πÀ≠‘ß μ—«Õ¬à“߇ªìπÀ≠‘ߪ√–™“°√°≈ÿࡇªÑ“À¡“¬√–¥—∫ª√–‡Σ» à«πΣ’Ë 2 °“√»÷°…“„π°≈ÿࡺŸâ„Àâ∫√‘°“√ 1) √Ÿª·∫∫°“√»÷°…“ ‡ªìπ°“√ ”√«®¿“§μ—¥¢«“ß (cross-sectional survey) 2) ª√–™“°√·≈–°≈ÿà¡μ—«Õ¬à“ß ª√–™“°√ §◊Õ ºŸâ- „Àâ∫√‘°“√ ‰¥â·°à ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“πΣ’Ë‡°’ˬ«¢âÕß °—∫°“√§«∫§ÿ¡ ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß®“° ∂“π∫√‘°“√ ÿ¢¿“æ —ß°—¥°√–Σ√«ß “Π“√≥ ÿ¢ ‰¥â·°à ”π—°ß“π “Π“√≥ ÿ¢®—ßÀ«—¥ ( ®.) ”π—°ß“π “Π“√≥ ÿ¢Õ”‡¿Õ ( Õ.) ‚√ß欓∫“≈ (√æ.) ·≈– ∂“π’Õπ“¡—¬À√◊Õ‚√ß欓∫“≈ à߇ √‘¡ ÿ¢¿“æμ”∫≈ (√æ. μ.) „πæ◊ÈπΣ’Ë»÷°…“Σ—Èß 12 ®—ßÀ«—¥ ‚¥¬°≈ÿà¡ μ—«Õ¬à“ߧ√—Èßπ’È §◊Õ ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“πΣ—ÈßÀ¡¥„π ∂“π∫√‘°“√ ÿ¢¿“楗߰≈à“« 3) ¢π“¥μ—«Õ¬à“ß·≈–°“√‡≈◊Õ°μ—«Õ¬à“ß π—°«‘®—¬ ‡≈◊Õ°μ—«Õ¬à“ß·∫∫‡®“–®ß ‚¥¬‡≈◊Õ°ºŸâ„Àâ∫√‘°“√®“° ®. Õ. √æ. ·≈–√æ. μ. Σ—ÈßÀ¡¥®”π«π 3,526 §π (ºŸâªØ‘∫—μ‘ß“π 2,827 §π·≈–ºŸâ∫√‘À“√ 699 §π) ‚¥¬ ºŸâ∫√‘À“√‡ªìπºŸâΣ’ËΣ”Àπâ“Σ’Ë¥â“π°“√∫√‘À“√ ‡™àπ 𓬠·æΣ¬å “Π“√≥ ÿ¢®—ßÀ«—¥ “Π“√≥ ÿ¢Õ”‡¿Õ ºŸâÕ”π«¬ °“√À√◊Õ√ÕߺŸâÕ”π«¬°“√„π‚√ß欓∫“≈ √«¡∂÷ßÀ—«Àπâ“ °≈ÿà¡ß“π„π·ºπ° Ÿμ‘π√’‡«™ ‡«™°√√¡ —ߧ¡À√◊Õ‡«™- ªØ‘∫—쑧√Õ∫§√—«·≈–™ÿ¡™π ß“π à߇ √‘¡ ÿ¢¿“æ·≈– ªÑÕß°—π‚√§ Σˇ’°Ë’¬«¢âÕß°—∫°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°- ¡¥≈Ÿ° à«πºŸâªØ‘∫—μ‘ß“π‡ªìπºŸâΣ’ËΣ”ß“π‡°’Ë¬«¢âÕß°—∫°“√ §«∫§ÿ¡·≈–ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«® §—¥°√Õß ‡™àπ °≈ÿà¡ß“π§«∫§ÿ¡‚√§‰¡àμ‘¥μàÕ °≈ÿà¡ß“π à߇ √‘¡ ÿ¢¿“æ ΩÉ“¬‡«™°√√¡ —ߧ¡À√◊ÕΩÉ“¬‡«™ªØ‘∫—μ‘ §√Õ∫§√—«·≈–™ÿ¡™π ‡®â“Àπâ“Σ’Ë√æ. μ. ‡ªìπμâπ 4) ‡§√◊ËÕß¡◊Õ‡°Á∫¢âÕ¡Ÿ≈ ºŸâ«‘®—¬æ—≤π“·∫∫ Õ∫∂“¡(8) ®”π«π 2 ™ÿ¥ ™ÿ¥Σ’Ë 1 ·∫∫ Õ∫∂“¡ ”À√—∫ ºŸâ∫√‘À“√ ª√–°Õ∫¥â«¬§”∂“¡ 3 ¥â“π ‰¥â·°à 1) ¢âÕ¡Ÿ≈ ıÙÒ
5.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 Σ—Ë«‰ª·≈–°“√ªØ‘∫—μ‘ß“π 2) §«“¡§‘¥‡ÀÁπμàÕπ‚¬∫“¬ ·≈–°“√„Àâ∫√‘°“√μ√«®§—¥°√Õß 3) ªí≠À“·≈–Õÿª √√§ ™ÿ¥Σ’Ë 2 ‡ªìπ·∫∫ Õ∫∂“¡ ”À√—∫ºŸâªØ‘∫—μ‘ß“π‚¥¬‡æ‘Ë¡ ‡μ‘¡„π 3 ¥â“π‰¥â·°à 4) ª√–«—μ‘°“√‡¢â“√—∫°“√Õ∫√¡ 5) §«“¡√Ÿâ‡°’ˬ«°—∫°“√μ√«®§—¥°√Õß 6) ¢âÕ¡Ÿ≈°“√„Àâ ∫√‘°“√μ√«®§—¥°√ÕߢÕß ∂“π欓∫“≈·≈– 7) §«“¡ ‡ÀÁπμàÕ°“√‡¢â“√—∫∫√‘°“√¢ÕßÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ 5) «‘Π’‡°Á∫¢âÕ¡Ÿ≈ π—°«‘®—¬ àß·∫∫ Õ∫∂“¡‰ª¬—ß°≈ÿà¡ μ—«Õ¬à“ßΣ“ß‰ª√…≥’¬å‚¥¬·π∫´Õß®¥À¡“¬ √“¬ ≈–‡Õ’¬¥·≈–Σ’ËÕ¬Ÿà‡æ◊ËÕ àß°≈—∫ πÕ°®“°π—Èππ—°«‘®—¬‰¥â ª√– “πß“π√à«¡°—∫‡®â“Àπâ“Σ’ËΩÉ“¬§«∫§ÿ¡‚√§‰¡àμ‘¥μàÕ ¢Õß ”π—°ß“π “Π“√≥ ÿ¢®—ßÀ«—¥‡æ◊ËÕμ‘¥μ“¡°“√ àß ·∫∫ Õ∫∂“¡Σ“ß®¥À¡“¬À√◊Õ‡ªìπºŸâ√«∫√«¡ ·∫∫ Õ∫∂“¡·≈â« àß¡“„Àâπ—°«‘®—¬Õ’°§√—Èß 6) °“√«‘‡§√“–Àå¢âÕ¡Ÿ≈ 1. „™â ∂‘쑇™‘ßæ√√≥“ ‰¥â·°à §à“§«“¡∂’Ë √âÕ¬≈– —¥ à«π §à“‡©≈’ˬ·≈– à«π‡∫’ˬ߇∫π¡“μ√∞“π‡æ◊ËÕ ÕΠ‘∫“¬≈—°…≥–Σ—Ë«‰ª √«¡Σ—ÈßÕΠ‘∫“¬§«“¡√Ÿâ §«“¡ ‡¢â“„®·≈–§«“¡§‘¥‡ÀÁπμàÕ√–∫∫°“√„Àâ∫√‘°“√/π‚¬∫“¬ 2. «‘‡§√“–Àå¢âÕ¡Ÿ≈¥â“πªí≠À“/Õÿª √√§·≈–¢âÕ ‡ πÕ·π–„π°“√„Àâ∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° „™â°“√®—¥À¡«¥À¡Ÿà·≈–«‘‡§√“–Àå‡æ◊ËÕ √ÿª‡π◊ÈÕÀ“ °“√μ√«® Õ∫‡§√◊ËÕß¡◊Õ ·∫∫ —¡¿“…≥åÀ≠‘ß°≈ÿࡇªÑ“À¡“¬·≈–·∫∫ Õ∫∂“¡ºŸâ„Àâ∫√‘°“√‰¥âºà“π°“√μ√«® Õ∫§«“¡μ√߇™‘ß ‡π◊ÈÕÀ“‚¥¬ºŸâΣ√ߧÿ≥«ÿ≤‘®”π«π 5 §π (‚§√ß°“√ ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈–π‚¬∫“¬¥â“π ÿ¢¿“æ 2 §π ∂“∫—π¡–‡√Áß·Ààß™“μ‘ °√¡°“√·æΣ¬å 1 §π ·≈–°√¡ Õπ“¡—¬ 2 §π) ·≈–Σ¥ Õ∫°—∫°≈ÿࡇªÑ“À¡“¬®”π«π 60 §πΣ’ËÕ¬ŸàπÕ°æ◊ÈπΣ’Ëμ—«Õ¬à“ß ¥â«¬°“√ —¡¿“…≥åμàÕμ—«μàÕ °—∫°≈ÿࡇªÑ“À¡“¬ Σ¥ Õ∫¢âÕ§”∂“¡‡√◊ËÕߧ«“¡√Ÿâ·≈– Σ—»π§μ‘‚¥¬æ‘®“√≥“¢âÕ§”∂“¡Σ’Ë¡’Õ”π“®®”·π°¡“° °«à“ 1.75 À≈—ß®“°π—ÈπΣ¥ Õ∫§«“¡πà“‡™◊ËÕ∂◊Õ‚¥¬„™â —¡ª√– ‘ΣΠ‘Ï·Õ≈ø“¢Õߧ√Õπ∫“§ „π¢âÕ§”∂“¡‡√◊ËÕß §«“¡√Ÿâ·≈–Σ—»π§μ‘‡À≈à“π—È𠉥â‡Σà“°—∫ 0.82 ·≈– 0.89 à«π·∫∫ Õ∫∂“¡ ”À√—∫ºŸâ„Àâ∫√‘°“√π—Èπ‰¥â𔉪 Σ¥ Õ∫°—∫ºŸâªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√®”π«π 20 §πΣ’Ë Õ¬ŸàπÕ°æ◊ÈπΣ’Ëμ—«Õ¬à“ß ‚¥¬¢Õ„Àâ°√Õ°¢âÕ¡Ÿ≈·≈– Õ∫∂“¡§«“¡‡¢â“„® §«“¡¬“°ßà“¬·≈–§«“¡ §√Õ∫§≈ÿ¡¢Õ߇π◊ÈÕÀ“‡æ‘Ë¡‡μ‘¡ æ‘®“√≥“‡≈◊Õ°¢âÕ§”∂“¡ ª√—∫ª√ÿß ·°â‰¢¥â«¬°“√ª√–™ÿ¡¢Õ§«“¡§‘¥‡ÀÁπ®“° ºŸâ‡™’ˬ«™“≠·≈–ºŸâΣ√ߧÿ≥«ÿ≤‘ °“√§«∫§ÿ¡§ÿ≥¿“æß“π«‘®—¬ ¡’°“√§«∫§ÿ¡§ÿ≥¿“æ°“√‡°Á∫¢âÕ¡Ÿ≈¢Õßπ—°«‘®—¬ ®“° ºŸâ‡™’ˬ«™“≠·≈–Σ’Ëª√÷°…“‚§√ß°“√«‘®—¬„π√–¥—∫æ◊ÈπΣ’Ë πÕ°®“°π—Èπ‰¥âπ”‡¢â“·≈–μ√«® Õ∫¢âÕ¡Ÿ≈„™â‚ª√·°√¡ §Õ¡æ‘«‡μÕ√å OMERET(9) ‡æ◊ËÕ≈¥§«“¡º‘¥æ≈“¥Σ’ˇ°‘¥ ®“°¡πÿ…¬å √«¡Σ—Èß¡’°“√𔇠πÕ§«“¡°â“«Àπâ“·≈– ª√÷°…“ºŸâ‡™’ˬ«™“≠®”π«π 2 §√—Èß °“√æ‘Σ—°…å ‘ΣΠ‘ºŸâ„Àâ¢âÕ¡Ÿ≈ ºŸâ«‘®—¬·≈–Σ’¡‡°Á∫¢âÕ¡Ÿ≈·®âß√“¬≈–‡Õ’¬¥‚§√ß°“√ ·≈–«—μ∂ÿª√– ߧåß“π«‘®—¬ √«¡Σ—Èߺ≈ª√–‚¬™πåΣ’Ë‰¥â√—∫ ®“°°“√„Àâ¢âÕ¡Ÿ≈·°àÀ≠‘ßμ—«Õ¬à“ß·≈– à«π√«¡ ´÷ËßÀ≈—ß Σ√“∫¢âÕ¡Ÿ≈·≈â«®–≈ß≈“¬¡◊Õ™◊ËÕ„Àâ¢âÕ¡Ÿ≈¥â«¬§«“¡ ‡μÁ¡„®°àÕπ°“√ —¡¿“…≥å·≈–À“°‰¡àÕ¬“°μÕ∫§”∂“¡ À√◊Õ¢Õ¬ÿμ‘√–À«à“ß°“√„Àâ —¡¿“…≥å°Á “¡“√∂Σ”‰¥â·≈– ‰¡à¡’º≈‡ ’¬„¥ Ê Σ—Èß ‘Èπ Õ’°Σ—ÈߢâÕ¡Ÿ≈Σ’Ë‰¥â®–ªî¥‡ªì𠧫“¡≈—∫‰¡à‡º¬·æ√à‡ªìπ√“¬∫ÿ§§≈ ·≈–·∫∫ —¡¿“…≥å ‡À≈à“π—Èπ®–∂Ÿ°Σ”≈“¬‡¡◊ËÕæâπ√–¬– 5 ªï º≈°“√»÷°…“ º≈°“√»÷°…“·∫àßÕÕ°‡ªìπ 3 à«π‰¥â·°à à«πΣ’Ë 1 ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ√—∫∫√‘°“√ ‰¥â·°à ¢âÕ¡Ÿ≈≈—°…≥–ª√–™“°√ ¢âÕ¡Ÿ≈ ∂“𖇻√…∞°‘® ·≈– —ߧ¡ ·≈–≈—°…≥–¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–°“√ªØ‘∫—μ‘ß“π ¢ÕߺŸâ„Àâ∫√‘°“√ à«πΣ’Ë 2 º≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘πß“π‚§√ß°“√ 542 Journal of Health Science 2012 Vol. 21 No. 3
6.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 §—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å ·≈–«’‰Õ æ.». 2548 - æ.». 2552 à«πΣ’Ë 3 ªí®®—¬Σ’ˇ°’ˬ«¢âÕßμàÕº≈ —¡ƒΣΠ‘Ï¢Õß°“√ ¥”‡π‘π‚§√ß°“√oe ·∫à߇ªìπªí®®—¬¥â“πºŸâ√—∫∫√‘°“√·≈– ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ 1. ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ√—∫∫√‘°“√ ºŸâ√—∫∫√‘°“√μÕ∫§”∂“¡ —¡¿“…≥凪ìπ®”π«πΣ—Èß ‘Èπ 4,512 §π (Õ—μ√“„À⧫“¡√à«¡¡◊Õ 97%) à«π„À≠àæ—° Õ“»—¬„πæ◊ÈπΣ’Ë„°≈âÀ√◊ÕÀà“ß®“°Õ”‡¿Õ‡¡◊Õߪ“π°≈“ß (ª√–¡“≥ 10-40 °‘‚≈‡¡μ√) (43%) ¡’Õ“¬ÿ‡©≈’ˬ 46 ªï à«π„À≠à¡’Õ“¬ÿ√–À«à“ß 40-49 ªï (40%) ¡’ ∂“π¿“æ §Ÿà·≈–Õ¬Ÿà√à«¡°—π°—∫§Ÿà ¡√ (80%) ‡°◊Õ∫Σ—ÈßÀ¡¥π—∫∂◊Õ »“ π“æÿΣΠ (95%) à«π„À≠à®∫°“√»÷°…“„π√–¥—∫ ª√–∂¡»÷°…“ (72%) ª√–°Õ∫Õ“™’懰…μ√°√√¡ (41%) √“¬‰¥âμàÕ‡¥◊Õπ¡’§à“°≈“ßÀ√◊Õ§à“¡—Π¬∞“πΣ’Ë 7,350 ∫“Σ à«π„À≠à (96%) ‡§¬¡’‡æ» —¡æ—πΠå ‚¥¬√âÕ¬≈– 68 ¡’ ‡æ» —¡æ—πΠå§√—Èß·√°‡¡◊ËÕÕ“¬ÿ 17-25 ªï à«π„À≠à (87%) ‡§¬§ÿ¡°”‡π‘¥ ·≈–√âÕ¬≈– 94 ‰¡à‡§¬ Ÿ∫∫ÿÀ√’Ë (μ“√“ßΣ’Ë 1) πÕ°®“°π—Èπ ºŸâ√—∫∫√‘°“√√âÕ¬≈– 96 √—∫√Ÿâ¢âÕ¡Ÿ≈ ¢à“« “√‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß ‚¥¬ à«π„À≠à√—∫√Ÿâ®“° ◊ËÕ∫ÿ§§≈À√◊Õ‡®â“Àπâ“Σ’Ë √Õß≈ß¡“ §◊Õ ◊ËÕ “Π“√≥– ‡™àπ ‚Σ√Σ—»πå ‘Ëßæ‘¡æå «‘Σ¬ÿ°√–®“¬ ‡ ’¬ß ‡ªìπμâπ 2. ≈—°…≥–¢ÕߺŸâ„Àâ¢âÕ¡Ÿ≈„π°≈ÿࡺŸâ„Àâ∫√‘°“√ (ºŸâ- ªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√) 2.1 ºŸâªØ‘∫—μ‘ß“π ·∫∫ Õ∫∂“¡Σ’ˉ¥â√—∫°≈—∫§◊π®“°ºŸâªØ‘∫—μ‘ß“π¡’ ®”π«π 1,525 ™ÿ¥ (Õ—μ√“μÕ∫°≈—∫√âÕ¬≈– 54) æ∫«à“ ºŸâªØ‘∫—μ‘ß“π à«π„À≠à‡ªìπ‡æ»À≠‘ß (92%) ¡’Õ“¬ÿ‡©≈’ˬ 40 ªï ¡’Õ“¬ÿ√–À«à“ß 40-49 ªï (43%) ¥”√ßμ”·Àπàß ‡®â“æπ—°ß“πÀ√◊Õπ—°«‘™“°“√ “Π“√≥ ÿ¢ (51%) ·≈– 欓∫“≈ (48%) à«π„À≠àªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ë¡“μ—Èß·μà 5 ªï¢÷Èπ‰ª (58%) ¡’∫Σ∫“Σ√—∫º‘¥™Õ∫ß“πΣ—Èß«“ß·ºπ ¥â“π°“√ à߇ √‘¡ ªÑÕß°—π·≈–ªØ‘∫—μ‘°“√μ√«®§—¥°√Õß «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û μ“√“ßΣ’Ë1 ¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–æƒμ‘°√√¡ ÿ¢¿“æ¢ÕßÀ≠‘ßμ—«Õ¬à“ß ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– æ◊ÈπΣ’Ëæ—°Õ“»—¬ (n = 4,512 §π) ‡¢μ‡¡◊Õß 1,633 36.2 ‡¢μ„°≈âÀ√◊ÕÀà“߇¡◊Õߪ“π°≈“ß 1,931 42.8 ‡¢μ‰°≈‡¡◊Õß 948 21.0 Õ“¬ÿ (ªï) (n = 4,512 §π) 30-39 1,291 28.6 40-49 1,785 39.6 ≥ 50 1,436 31.8 Mean (SD) / Median (45.7 (8.0) / 46) ∂“π¿“æ (n = 4,505 §π) ‚ ¥ 187 4.2 ¡’§Ÿà·≈–Õ¬Ÿà¥â«¬°—π 3,609 80.1 À¬à“/·¬°°—πÕ¬Ÿà/À¡â“¬ 709 15.7 »“ π“ (n = 4,513 §π) æÿΣΠ 4,273 94.7 §√‘ μå 33 0.7 Õ‘ ≈“¡ 207 4.6 °“√»÷°…“ (n = 4,512 §π) ‰¡à‰¥â»÷°…“ 198 4.4 ª√–∂¡»÷°…“ 3,258 72.1 ¡—Π¬¡»÷°…“μÕπμâπ 429 9.5 ¡—Π¬¡»÷°…“μÕπª≈“¬/ª«™. 359 8.0 Õπÿª√‘≠≠“/ª« . 112 2.5 ª√‘≠≠“μ√’À√◊Õ Ÿß°«à“ 156 3.5 Õ“™’æ (n = 4,512) «à“ßß“π/‰¡à‰¥âª√–°Õ∫Õ“™’æ 248 5.5 ·¡à∫â“π 483 10.7 ‡°…μ√°√√¡ 1,842 40.8 √—∫®â“ß 1,044 23.1 √—∫√“™°“√/æπ—°ß“π√—∞«‘ “À°‘® 63 1.4 æπ—°ß“π‡Õ°™π 25 0.6 §â“¢“¬/Πÿ√°‘® à«πμ—« 807 17.9 ıÙÛ
7.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 μ“√“ßΣ’Ë1(μàÕ) ¢âÕ¡Ÿ≈Σ—Ë«‰ª·≈–æƒμ‘°√√¡ ÿ¢¿“æ¢ÕßÀ≠‘ßμ—«Õ¬à“ß ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– √“¬‰¥â (∫“ΣμàÕ‡¥◊Õπ) (n = 4,512 §π) ≤ 5,000 1,607 35.6 5,000 - 10,000 1,594 35.3 10,001 - 15,000 537 11.9 >15,000 774 17.2 Range / Mean (SD) / Median (250-900,000 / 11,393 (21,027) / 7,350) ª√–«—μ‘°“√¡’‡æ» —¡æ—πΠå (n = 4,512 §π) ‰¡à‡§¬ 170 3.8 ‡§¬ 4,342 96.2 Õ“¬ÿ‡¡◊ËÕ¡’‡æ» —¡æ—πΠå§√—Èß·√° (ªï) (n = 4,335 §π) < 17 834 19.2 17-25 2,933 67.7 > 25 568 13.1 °“√§ÿ¡°”‡π‘¥ (n = 4,338 §π) ‰¡à‡§¬ 579 13.3 ‡§¬·μàªí®®ÿ∫—π‰¡à‰¥â§ÿ¡ 1,257 29.0 ‡§¬·≈–ªí®®ÿ∫—π§ÿ¡ 2,502 57.7 ª√–«—μ‘°“√ Ÿ∫∫ÿÀ√’Ë (n = 4,512 §π) ‰¡à‡§¬ 4,257 94.4 ‡§¬·μàªí®®ÿ∫—π‰¡à‰¥â Ÿ∫ 78 1.7 ‡§¬·≈–ªí®®ÿ∫—π Ÿ∫ 177 3.9 °“√√—∫√Ÿâ¢âÕ¡Ÿ≈¢à“« “√¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß (n = 4,512 §π) ‡§¬ 4,350 96.4 ‰¡à‡§¬ 162 3.6 ·À≈àßΣ’Ë¡“¢Õß°“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√ (n = 4,512 §π) ‡®â“Àπâ“Σ’Ë √æ. μ./√æ. 3,339 74.0 Õ ¡. 970 21.5 ‡æ◊ËÕπ §π√Ÿâ®—°§ÿâπ‡§¬·≈– ¡“™‘°„π§√Õ∫§√—« 938 20.8 ‚Σ√Σ—»πå 2,667 59.1 ◊ËÕ ‘Ëßæ‘¡æå 578 12.8 «‘Σ¬ÿ°√–®“¬‡ ’¬ß/ÀÕ°√–®“¬¢à“« 429 9.5 μ“√“ßΣ’Ë2 ¢âÕ¡Ÿ≈Σ—Ë«‰ª¢ÕߺŸâªØ‘∫—μ‘ß“π„π ∂“π∫√‘°“√ ÿ¢¿“æ ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– ‡æ» (n = 1,525 §π) ™“¬ À≠‘ß Õ“¬ÿ (ªï) (n = 1,522 §π) < 30 30-39 40-49 119 1,406 182 533 656 151 ≥ 50 Mean (SD.) / Median (39.62 (8.1) / 40) μ”·Àπàß (n = 1,524 §π) ‡®â“æπ—°ß“π/π—°«‘™“°“√ “Π“√≥ ÿ¢ 欓∫“≈ Õ◊Ëπ Ê ( Ÿμ‘·æΣ¬å/·æΣ¬åª√–®”∫â“π) Àπâ“Σ’Ë√—∫º‘¥™Õ∫ (n = 1,518 §π) «“ß·ºπ/ à߇ √‘¡/ª√–™“ —¡æ—πΠå μ√«®§—¥°√Õß Σ—Èß Õߥâ“π§«∫§Ÿà°—π ª√– ∫°“√≥å„π°“√ªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ë (ªï) (n = 1,479 §π) < 5 ≥ 5 ª√–«—μ‘°“√Õ∫√¡ (n = 1,525 §π) «‘Π’·ªª ‡¡’¬√å 779 725 20 228 99 1,191 619 860 1,222 303 221 1,304 7.8 92.2 12.0 35.0 43.1 9.9 51.1 47.6 1.3 15.0 6.5 78.5 41.9 58.1 ‡§¬ 80.1 ‰¡à‡§¬ 19.9 «‘Π’«’‰Õ‡Õ ‡§¬ 14.5 ‰¡à‡§¬ 85.5 °“√„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë‡¡ËÕ‡◊Σ’¬∫°—∫ ªí≠À“ ÿ¢¿“æÕ◊Ëπ (n = 1,525 §π) √–¥—∫¡“° 612 √–¥—∫ª“π°≈“ß 688 √–¥—∫πâÕ¬ 226 °“√„À⧫“¡ ”§—≠μàÕ°“√μ√«®§—¥°√Õß (n = 1,525 §π) √–¥—∫¡“° 1,246 √–¥—∫ª“π°≈“ß 241 √–¥—∫πâÕ¬ 38 40.1 45.1 14.8 81.7 15.8 2.5 544 Journal of Health Science 2012 Vol. 21 No. 3
8.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 (79%) ·≈– à«π„À≠àºà“π°“√Õ∫√¡°“√μ√«®§—¥°√Õß ¥â«¬«‘Π’·ªª ‡¡’¬√å (80%) ·μà¡’‡æ’¬ß∫“ß à«πΣ’Ë‡§¬‰¥â √—∫°“√Õ∫√¡°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ (15%) (μ“√“ßΣ’Ë 2) 2.2 ºŸâ∫√‘À“√ ·∫∫ Õ∫∂“¡Σ’ˉ¥â√—∫§◊π®“°ºŸâ∫√‘À“√¡’®”π«π 418 ™ÿ¥ (Õ—μ√“μÕ∫°≈—∫√âÕ¬≈– 57) æ∫«à“ºŸâ∫√‘À“√ ‚§√ß°“√√–¥—∫®—ßÀ«—¥ à«π„À≠àΣ”ß“π„π‚√ß欓∫“≈ (54%) ‡ªìπ‡æ»À≠‘ß (53%) ¥”√ßμ”·Àπàßπ—°«‘™“°“√ “Π“√≥ ÿ¢ (49%) ¡’√–¬–‡«≈“„π°“√ªØ‘∫—μ‘ß“π„π æ◊ÈπΣ’Ëªí®®ÿ∫—π¡“°°«à“ 10 ªï (53%) ´÷Ëß‚¥¬ à«π„À≠à„Àâ §«“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¡“°‡¡◊ËÕ‡ª√’¬∫ ‡Σ’¬∫°—∫ªí≠À“ ÿ¢¿“æÕ◊Ëπ Ê (53%) (μ“√“ßΣ’Ë 3) 3. º≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘πß“π‚§√ß°“√§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - æ.». 2552 „π à«π¢ÕßÕ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ°„π 5 ªïΣ’Ëºà“π¡“π—Èπ °≈ÿà¡μ—«Õ¬à“ߢÕß Σÿ°¿“§¡’Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß„°≈⇧’¬ß °—π§◊Õª√–¡“≥√âÕ¬≈– 65-70 ‚¥¬Õ—μ√“°“√‡¢â“√—∫ ∫√‘°“√‡©≈’ˬΣÿ°¿“§„π√–¥—∫ª√–‡Σ» §‘¥‡ªìπ√âÕ¬≈– 68 (95% CI 65, 70) (μ“√“ßΣ’Ë 4) ºŸâ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß à«π„À≠à (88%) ‰¥â √—∫°“√μ√«®¥â«¬«‘Π’·ªª ‡¡’¬√å ·≈–«‘Π’«’‰Õ‡Õ‡æ’¬ß√âÕ¬≈– 7 ‚¥¬ √æ. μ. ‡ªìπ ∂“π欓∫“≈À≈—°Σ’ËÀ≠‘߇¢â“√—∫∫√‘°“√ (50%) √–¬–‡«≈“√Õº≈À≈—ß√—∫°“√μ√«®§—¥°√Õߥ⫬ «‘Π’·ªª ‡¡’¬√å à«π„À≠à (39%) Õ¬Ÿà√–À«à“ß 2-4 —ª¥“Àå ·≈–√âÕ¬≈– 31 Σ√“∫º≈®“°°“√ÕΠ‘∫“¬¢Õ߇®â“Àπâ“Σ’Ë „π«—πμ√«® §◊Õ ç‡®â“Àπâ“Σ’Ë®–·®âߺ≈„ÀâΣ√“∫‡©æ“– °√≥’æ∫§«“¡º‘¥ª√°μ‘‡Σà“π—Èπé à«πºŸâ√—∫°“√μ√«®¥â«¬ «‘Π’«’‰Õ‡Õ‡°◊Õ∫Σ—ÈßÀ¡¥ (90%) Σ√“∫º≈„π«—πμ√«® (μ“√“ßΣ’Ë 5) “‡Àμÿ¢Õß°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ‰¥â·°à °“√Σ’ËÕ“ “ ¡—§√ “Π“√≥ ÿ¢ À√◊Õ‡®â“Àπâ“Σ’Ë¢Õß √æ. μ./ √æ.·π–π”„À≪μ√«®§—¥°√Õß (50%) μâÕß°“√μ√«® «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û μ“√“ßΣ’Ë3 ¢âÕ¡Ÿ≈Σ—Ë«‰ª¢ÕߺŸâ∫√‘À“√‚§√ß°“√√–¥—∫®—ßÀ«—¥„π ∂“π∫√‘°“√ ÿ¢¿“æ ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– Àπ૬ߓπ/ ∂“πΣ’Ë (n = 401 §π) ®. 12 3.0 Õ. 174 43.4 √æ. 215 53.6 ‡æ» (n = 418) ™“¬ 198 47.4 À≠‘ß 220 52.6 μ”·Àπàß/ “¬ß“π (n = 418 §π) π—°«‘™“°“√ 206 49.3 欓∫“≈ 102 24.4 Ÿμ‘·æΣ¬å 12 2.8 ·æΣ¬å 98 23.5 √–¬–‡«≈“ªØ‘∫—μ‘ß“π„πæ◊ÈπΣ’Ëªí®®ÿ∫—π (ªï) (n = 391 §π) < 5 117 29.9 5 - 10 66 16.9 > 10 208 53.2 °“√„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áߪ“°¡¥≈Ÿ° (n = 418 §π) √–¥—∫πâÕ¬ 77 18.3 √–¥—∫ª“π°≈“ß 118 28.3 √–¥—∫¡“° 223 53.4 §«“¡‡ÀÁπμàÕ°“√¡’ 2 «‘Π’μ√«®§—¥°√Õß¿“¬„π®—ßÀ«—¥ (n = 355 §π) ‡ÀÁπ¥â«¬ 284 80.0 ‰¡à‡ÀÁπ¥â«¬ 36 10.1 ‰¡à· ¥ß§«“¡§‘¥‡ÀÁπ 35 9.9 ÿ¢¿“æ¢Õßμπ‡Õß ‡æ√“– π„® „ à„® ÿ¢¿“æμπ‡Õß À√◊Õ°≈—«‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° (38%) ·≈–¡’Õ“°“√º‘¥ ª√°μ‘ ‡™àπ ¡’‡≈◊Õ¥ÕÕ°Σ“ß™àÕߧ≈Õ¥ μ°¢“«º‘¥ª√°μ‘ (11%) à«π “‡ÀμÿÀ≈—°Σ’Ë°≈ÿà¡μ—«Õ¬à“߉¡à‰ªμ√«®§—¥°√Õß ‰¥â·°à °“√Σ’Ë§‘¥«à“μπ‡Õ߉¡à¡’Õ“°“√º‘¥ª√°μ‘ (37%) §‘¥«à“μπ‰¡à‡ ’ˬ߇ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° (23%) ‰¡à¡’‡«≈“ (18%) ·≈–Õ“¬‡®â“Àπâ“Σ’Ë (17%) ıÙı
9.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 μ“√“ßΣ’Ë4 °“√ª√–¡“≥Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕßÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ ®”π«π ®”π«π Õ—μ√“°“√√—∫ §«“¡§≈“¥‡§≈◊ËÕπ ™à«ß§«“¡‡™◊ËÕ¡—Ëπ °≈ÿà¡ ª√–™“°√À≠‘ß ∫√‘°“√μ√«®„π ¡“μ√∞“π (95%CI) μ—«Õ¬à“ß °≈ÿࡇªÑ“À¡“¬ ª√–™“°√À≠‘ß (SE) lower upper (ª√—∫¥â«¬§à“∂à«ßπÈ”Àπ—°) ‡ªÑ“À¡“¬ (%) Σ—Ë«ª√–‡Σ» μ√«® 3,164 9,137,381 68 1.2 65 70 ‰¡àμ√«® 1,348 4,382,910 32 1.2 30 35 √«¡ 4,512 13,520,291 100 ‡Àπ◊Õ μ√«® 947 1,983,416 70 2.7 64 75 ‰¡àμ√«® 345 866,709 30 2.7 25 36 √«¡ 1,292 2,850,125 100 μ–«—πÕÕ°‡©’¬ß‡Àπ◊Õ μ√«® 705 3,377,522 69 2.1 64 73 ‰¡àμ√«® 267 1,534,455 31 2.1 27 36 √«¡ 972 4,911,977 1.00 °≈“ß/μ–«—πÕÕ°/μ–«—πμ° μ√«® 633 2,500,554 65 2.8 59 71 ‰¡àμ√«® 333 1,344,653 35 2.8 29 41 √«¡ 966 3,845,207 100 „μâ μ√«® 878 1,275,889 67 2.2 62 71 ‰¡àμ√«® 404 637,093 33 2.2 29 38 √«¡ 1,282 1,912,982 100 4. ªí®®—¬Σ’ˇ°’ˬ«¢âÕßμàÕº≈ —¡ƒΣΠ‘Ï¢Õß°“√¥”‡π‘𠂧√ß°“√oe ·∫à߇ªìπªí®®—¬¥â“πºŸâ√—∫∫√‘°“√·≈–ªí®®—¬ ¥â“πºŸâ„Àâ∫√‘°“√ 4.1 ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√ °“√«‘‡§√“–ÀåÀ“ªí®®—¬Σ’Ë¡’º≈μàÕ°“√‡¢â“√—∫ ∫√‘°“√μ√«®§—¥°√ÕߢÕß°≈ÿà¡μ—«Õ¬à“ßæ∫«à“ ªí®®—¬À≈—° Σ’Ë à߇ √‘¡„À⇢â“√—∫∫√‘°“√ ‰¥â·°à °“√√—∫Σ√“∫¢âÕ¡Ÿ≈ °≈à“«§◊Õ °“√Σ’Ë°≈ÿà¡μ—«Õ¬à“߇§¬‰¥â√—∫¢âÕ¡Ÿ≈‡°’ˬ«°—∫ ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß®–¡’‚Õ°“ ‡¢â“ √—∫°“√μ√«®§—¥°√Õ߇ªìπ 2.5 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‡§¬‰¥â√—∫ ¢âÕ¡Ÿ≈ (OR 2.5, 95%CI 1.7, 3.8) √Õß≈ß¡“‰¥â·°à §«“¡ ‡¢â“„®‡°’ˬ«°—∫°“√μ√«®§—¥°√Õß ‚¥¬ºŸâΣ’Ë‡¢â“„®∂Ÿ°μâÕß «à“°“√‰ªμ√«®§—¥°√Õ߇ªìπª√–®”μ“¡°”Àπ¥®–Σ”„Àâ ª≈Õ¥¿—¬®“°°“√‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° ¡’‚Õ°“ Σ’Ë®–‡¢â“ √—∫∫√‘°“√‡ªìπ 1.7 ‡Σà“¢ÕߺŸâΣ’Ë‡¢â“„®º‘¥ (OR 1.7, 95%CI 1.2, 2.7) πÕ°®“°π’È ªí®®—¬ à«π∫ÿ§§≈ —ߧ¡ ‡»√…∞°‘® ¬—ß¡’§«“¡ ”§—≠μàÕ°“√‡¢â“√—∫°“√μ√«®§—¥°√Õß ‚¥¬ æ∫«à“ºŸâΣ’Ëª√–°Õ∫Õ“™’懰…μ√°√√¡¡’‚Õ°“ ‡¢â“√—∫°“√ μ√«®§—¥°√Õ߇ªìπ 1.9 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‰¥âΣ”ß“πÀ√◊Õ‡ªìπ ·¡à∫â“π (OR 1.9, 95%CI 1.3, 2.7) ºŸâΣ’ËÕ“»—¬„π‡¢μ 546 Journal of Health Science 2012 Vol. 21 No. 3
10.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 μ“√“ßΣ’Ë5 √“¬≈–‡Õ’¬¥°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¢âÕ¡Ÿ≈ ®”π«π √âÕ¬≈– «‘Π’Σ’Ë„™âμ√«®§—¥°√Õß (n =3,164 §π) «‘Π’·ªª ‡¡’¬√å 2,794 88.3 «‘Π’«’‰Õ‡Õ 221 7.0 ‰¡àΣ√“∫«‘Π’ 149 4.7 ∂“πΣ’Ëμ√«® (n =3,164 §π) ∂“π’Õπ“¡—¬/√æ. μ. 1,582 50.0 ‚√ß欓∫“≈¢Õß√—∞ 956 30.2 ‚√ß欓∫“≈À√◊Õ§≈’π‘°‡Õ°™π 471 14.9 Àπ૬∫√‘°“√‡§≈◊ËÕπΣ’Ë 155 4.9 √–¬–‡«≈“Σ√“∫º≈μ√«®«‘Π’·ªª ‡¡’¬√å ( —ª¥“Àå) (n =3,162 §π) < 2 613 19.4 2-4 1,233 39.0 > 4 348 11.0 ·®âߺ≈‡©æ“–À“°μ√«®æ∫§«“¡º‘¥ª√°μ‘ 968 30.6 √–¬–‡«≈“Σ√“∫º≈μ√«®«‘Π’«’‰Õ‡Õ ( —ª¥“Àå) (n =3,158 §π) ‡®â“Àπâ“Σ’Ë·®âߺ≈„π«—πμ√«® °√≥’μâÕß°“√¬◊π¬—πº≈μ√«® 2,833 89.7 < 2 66 2.1 2-4 79 2.5 > 4 63 2.0 ·®âߺ≈‡©æ“–À“°μ√«®æ∫§«“¡º‘¥ª√°μ‘ 117 3.7 “‡ÀμÿÀ≈—°°“√‡¢â“√—∫∫√‘°“√ (n=3,164 §π) ‰¥â√—∫§”·π–π”®“° Õ ¡. ‡®â“Àπâ“Σ’Ë Õ./√æ. μ./√æ. 1,576 49.8 μâÕß°“√μ√«® ÿ¢¿“æ‡æ√“– π„® „ à„® ÿ¢¿“æ °≈—«‡ªìπ‚√§ 1,193 37.7 ¡’Õ“°“√º‘¥ª√°μ‘ ‡™àπ ¡’‡≈◊Õ¥ÕÕ°Σ“ß™àÕߧ≈Õ¥ μ°¢“«º‘¥ª√°μ‘ ‡ªìπμâπ 335 10.6 “¡’À√◊Õ∫ÿ§§≈„°≈♑¥·π–π” 32 1.0 “‡ÀμÿÀ≈—°°“√‰¡à‡¢â“√—∫∫√‘°“√ (n=1,348 §π) ‰¡à¡’Õ“°“√º‘¥ª√°μ‘ 497 36.9 §‘¥«à“μπ‡Õ߉¡à‡ ’ˬßμàÕ°“√‡ªìπ‚√§¡–‡√Áߪ“°¡¥≈Ÿ° 307 22.8 ‰¡à¡’‡«≈“‰ªμ√«®§—¥°√Õß 244 18.1 Õ“¬‡®â“Àπâ“Σ’Ë 222 16.5 ™π∫Σ¡’‚Õ°“ μ√«®§—¥°√Õ߇ªìπ 1.5 ‡Σà“¢ÕߺŸâΣ’ËÕ“»—¬ „π‡¢μ‡¡◊Õß (OR 1.5, 95%CI 1.2, 1.8) ºŸâΣ’Ë¡’Õ“¬ÿ√–À«à“ß 40-49 ªï¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√Õ߇ªìπ 1.5 ‡Σà“ ¢ÕߺŸâΣ’Ë¡’Õ“¬ÿ√–À«à“ß 30-39 ªï (OR 1.5, 95%CI 1.2, «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û 1.8) ·≈–ºŸâΣ’Ë‡§¬μ—Èߧ√√¿å¡’‚Õ°“ Σ’Ë®–‡¢â“√—∫°“√μ√«® §—¥°√Õ߇ªìπ 1.8 ‡Σà“¢ÕߺŸâΣ’Ë‰¡à‡§¬μ—Èߧ√√¿å (OR 1.8, 95%CI 1.2, 2.5) πÕ°®“°π—Èπ¬—ßæ∫ªí®®—¬Σ’ˇªìπÕÿª √√§μàÕ°“√‡¢â“ ıÙ˜
11.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 √ŸªΣ’Ë1 §à“ Odds ratio ·≈–™à«ß§«“¡‡™◊ËÕ¡—ËπΣ’Ë 95% ¢Õßªí®®—¬„πÀ≠‘ß°≈ÿà¡μ—«Õ¬à“ßΣ’Ë —¡æ—πΠå°—∫°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ° √—∫∫√‘°“√μ√«®§—¥°√Õß (√ŸªΣ’Ë 1) ‚¥¬‡©æ“–°“√Σ’Ë°≈ÿà¡ ‡ªÑ“À¡“¬¡’Σ—»π§μ‘Σ’Ë‰¡à¥’μàÕ°“√μ√«®§—¥°√Õß ´÷ËߺŸâΣ’Ë ‡ÀÁπ«à“°“√μ√«®§—¥°√Õ߇ªìπÕ—πμ√“¬¡“° ®–¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë‡ÀÁπ«à“‰¡à¡’ Õ—πμ√“¬∂÷ß√âÕ¬≈– 60 (OR 0.4, 95%CI 0.3, 0.7) √«¡Σ—ÈߺŸâΣ’Ë¡’§«“¡√Ÿâ ÷°«‘μ°°—ß«≈¡“°‚¥¬°≈—«®–μ√«® æ∫¡–‡√Áߪ“°¡¥≈Ÿ° ¡’‚Õ°“ μ√«®§—¥°√ÕßπâÕ¬°«à“ À≠‘ßΣ’Ë‰¡à«‘μ°À√◊Õ‰¡à°≈—«‡≈¬√âÕ¬≈– 30 (OR 0.7, 95%CI 0.6, 0.7) „π¥â“𧫓¡√Ÿâ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈– °“√μ√«®§—¥°√Õß°Áæ∫«à“‡ªìπªí®®—¬Σ’Ë ”§—≠¡“° ‚¥¬ ºŸâΣ’Ë‡¢â“„®º‘¥«à“∂â“μ√«®·≈⫉¡àæ∫§«“¡º‘¥ª√°μ‘°Á‰¡à μâÕß¡“μ√«®Õ’°‡≈¬ ®–¡’‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“ ºŸâΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ°μâÕß√âÕ¬≈– 50 (OR 0.5, 95%CI 0.4, 0.7) „π¢≥–Σ’ËºŸâΣ’Ë‡¢â“„®º‘¥«à“°“√μ√«®§—¥°√Õß Σ”‰¥â„π‚√ß欓∫“≈‡Σà“π—Èπ ¡’‚Õ°“ ‡¢â“√—∫°“√μ√«® §—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ°μâÕß√âÕ¬≈– 30 (OR 0.7, 95%CI 0.6, 0.9) ·≈–ºŸâΣ’Ë‡¢â“„®º‘¥À√◊Õ‰¡à Σ√“∫‡°’ˬ«°—∫Õ“°“√º‘¥ª√°μ‘¢Õß¡–‡√Áߪ“°¡¥≈Ÿ° ¡’ ‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡‡¢â“„®Σ’Ë∂Ÿ° μâÕß√âÕ¬≈– 20 (OR 0.8, 95%CI 0.7, 0.9) πÕ°®“° π—Èπ¬—ßæ∫«à“ ªí®®—¬ à«π∫ÿ§§≈ —ߧ¡ ‡»√…∞°‘® ·≈– æƒμ‘°√√¡ ÿ¢¿“æ°Á¡’§«“¡ —¡æ—πΠåμàÕ°“√‰¡à‡¢â“√—∫ ∫√‘°“√‡™àπ°—π ‚¥¬ºŸâΣ’Ëπ—∫∂◊ÕÕ‘ ≈“¡®–¡’‚Õ°“ ‡¢â“√—∫ °“√μ√«®§—¥°√ÕßπâÕ¬°«à“ºŸâΣ’Ëπ—∫∂◊Õ»“ π“æÿΣΠ√âÕ¬≈– 40 (OR 0.6, 95%CI 0.5, 0.9) ·≈–ºŸâΣ’Ë Ÿ∫∫ÿÀ√’Ë¡’ ‚Õ°“ ‡¢â“√—∫∫√‘°“√πâÕ¬°«à“ºŸâΣ’Ë‰¡à Ÿ∫√âÕ¬≈– 40 (OR 0.6, 95%CI 0.4, 0.8) 4.2 ªí®®—¬¥â“πºŸâ„Àâ∫√‘°“√ ”À√—∫§«“¡§‘¥‡ÀÁπμàÕπ‚¬∫“¬ªÑÕß°—π¡–‡√Áß ª“°¡¥≈Ÿ°√–¥—∫ª√–‡Σ»π—Èπ ºŸâªØ‘∫—μ‘ß“π‡ÀÁπ«à“¡–‡√Áß ª“°¡¥≈Ÿ°‡ªìπªí≠À“ ”§—≠„π√–¥—∫ª“π°≈“ß (45%) ·≈–√–¥—∫¡“° (40%) ‡¡◊ËÕ‡ª√’¬∫‡Σ’¬∫°—∫ªí≠À“ ÿ¢ ¿“æÕ◊ËπÊ ·≈– à«π„À≠à‡ÀÁπ«à“°“√μ√«®§—¥°√Õ߇ªìπ ·π«Σ“ßΣ’Ë®–™à«¬≈¥Õ—μ√“°“√‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ°‰¥â¡“° 548 Journal of Health Science 2012 Vol. 21 No. 3
12.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 (82%) (μ“√“ßΣ’Ë 2) ºŸâªØ‘∫—μ‘ß“π¡’§«“¡‡ÀÁπμàÕ«‘Π’·≈–°‘®°√√¡°“√ μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë ´÷Ëß à«π„À≠à¡’ §«“¡‡ÀÁπμàÕ°“√μ√«®§—¥°√ÕßΣ—Èß«‘Π’·ªª ‡¡’¬√å·≈– «’‰Õ‡Õ„π‡™‘ß∫«° ‚¥¬‡ÀÁπ¥â«¬„π√–¥—∫ª“π°≈“ßÀ√◊Õ √–¥—∫¡“°‡°◊Õ∫Σÿ°ª√–‡¥Áπ ·μà¡’ºŸâªØ‘∫—μ‘ß“π∫“ß à«π¡’ §«“¡‡ÀÁπ«à“ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ ß∫ª√–¡“≥ ·≈–§«“¡æ√âÕ¡¥â“πÕÿª°√≥å ‡§√◊ËÕß¡◊Õ ¢ÕßΣ—Èß Õß«‘Π’ §«√‰¥â√—∫°“√ª√—∫ª√ÿß ‚¥¬‡©æ“–®”π«π∫ÿ§≈“°√·≈– °“√®—¥ √√ß∫ª√–¡“≥¢Õß«‘Π’«’‰Õ‡ÕΣ’Ë‡ÀÁπ«à“¡’§àÕπ¢â“ß πâÕ¬ (49% ·≈– 54%) (√ŸªΣ’Ë 2) à«π„π¿“æ√«¡¢Õß°“√¥”‡π‘π°‘®°√√¡°“√μ√«® §—¥°√Õß„πæ◊ÈπΣ’Ë à«π„À≠à‡ÀÁπ¥â«¬„π√–¥—∫ª“π°≈“ß ‰¡à«à“®–‡ªìπª√–‡¥Áπ‡°’Ë¬«°—∫°‘®°√√¡°“√μ√«®§—¥°√Õß Σ’Ëºà“π¡“ °“√ª√–™“ —¡æ—πΠå √–∫∫√âÕ߇√’¬π·≈–°“√ ·°âªí≠À“ °“√π‘‡Σ» μ‘¥μ“¡ ª√–‡¡‘πº≈ ·≈–º≈°“√ ¥”‡π‘πß“πΣ’Ëºà“π¡“ ·μà¡’∫“ߪ√–‡¥ÁπΣ’ËºŸâªØ‘∫—μ‘ß“π ª√–¡“≥√âÕ¬≈– 40 ‡ÀÁπ«à“¬—ß¡’Õ¬Ÿà„π√–¥—∫πâÕ¬ ‡™à𠧫“¡æ√âÕ¡¥â“π‡§√◊ËÕß¡◊Õ Õÿª°√≥å §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ §«“¡√Ÿâ §«“¡™”π“≠¢Õß∫ÿ§≈“°√ §«“¡πà“‡™◊ËÕ¢Õß·μà≈–«‘Π’ §«“¡√«¥‡√Á«„π°“√ àßμàÕ‡æ◊ËÕ«‘π‘®©—¬/√—°…“ §«“¡ ¡∫Ÿ√≥å¢Õß√–∫∫√“¬ß“π °“√„™âª√–‚¬™π宓°∞“π¢âÕ¡Ÿ≈ °“√¬Õ¡√—∫¢Õß°≈ÿࡇªÑ“À¡“¬ °“√ª√– “πß“π„πæ◊ÈπΣ’Ë °“√ π—∫ πÿπ®“°ºŸâ∫√‘À“√ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥„π°“√¥”‡π‘π°‘®°√√¡ ®”π«π·≈–§«“¡ ¡Ë”‡ ¡Õ¢Õß°“√π‘‡Σ»μ‘¥μ“¡®“° à«π°≈“ß ‡ªìπμâπ (√ŸªΣ’Ë 3) „π¢≥–‡¥’¬«°—π ºŸâªØ‘∫—μ‘ß“π à«π„À≠à¡’§«“¡√Ÿâ∂Ÿ° μâÕ߇°Ë’¬«°—∫°“√μ√«®§—¥°√ÕßΣË’‡ªìπ à«π ”§—≠μàÕ°“√ ¥”‡π‘π°‘®°√√¡ ·μଗßæ∫«à“∫“ß à«π¡’§«“¡√Ÿâ·≈– §«“¡‡¢â“„®Σ’˺‘¥„πª√–‡¥Á𠔧—≠ ‚¥¬‡©æ“–Σ’Ë‡°’ˬ«°—∫ «‘Π’·≈–¢—ÈπμÕπ°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ (μ“√“ßΣ’Ë 6) „π¥â“πºŸâ∫√‘À“√ à«π„À≠à‡¢â“„®π‚¬∫“¬·≈– «—μ∂ÿª√– ߧ尓√μ√«®§—¥°√Õß„π√–¥—∫¡“° (82%) √«¡Σ—È߇ÀÁπ«à“°“√ π—∫ πÿπ®“° à«π°≈“ß °“√«“ß·ºπ ·≈–·π«Σ“ߪؑ∫—μ‘¿“¬„π®—ßÀ«—¥ §ÿ≥¿“æ¢Õß√–∫∫ ¢âÕ¡Ÿ≈·≈–°“√√“¬ß“π ®”π«π∫ÿ§≈“°√·≈–°“√Õ∫√¡ μ≈Õ¥®π°‘®°√√¡°“√μ√«®§—¥°√Õß„πæ◊ÈπΣ’ËΣ’Ëºà“π¡“Õ¬Ÿà „π√–¥—∫ª“π°≈“ß ·μà¡’ºŸâ∫√‘À“√ à«πÀπ÷Ë߇ÀÁπ«à“ ∫ÿ§≈“°√„π√–∫∫¬—ߢ“¥·§≈π (38%) °“√®—¥ √√ß∫ ª√–¡“≥¬—߉¡à‡æ’¬ßæÕ (32%) °“√Õ∫√¡‰¡à ¡Ë”‡ ¡Õ «‘Π’·ªª ‡¡’¬√å«Π‘«’‰’Õ‡Õ √ŸªΣ’Ë2 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâªØ‘∫—μ‘ß“πμàÕ°“√μ√«®¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ ıÙ˘
13.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 §«“¡‡æ’¬ßæÕ¢Õßß∫ª√–¡“≥ °“√μ√«®§—¥°√Õ߇ªìπ°“√‡æ‘Ë¡¿“√– ¡’§«“¡√Ÿâ‡æ◊ËÕ∂à“¬ΣÕ¥Õ¬à“߇撬ßæÕ §«“¡∂Ÿ°μâÕß ·¡àπ¬”¢Õß°“√μ√«® §«“¡À≈“°À≈“¬¢Õß°“√„Àâ∫√‘°“√ °‘®°√√¡°“√μ√«® §—¥°√ÕßΣ’Ëºà“π¡“ §«“¡√à«¡¡◊Õ¢Õß Õ ¡. À√◊Õ°≈ÿà¡·¡à∫â“𠧫“¡∂’Ë¢Õß°“√ª√–™“ —¡æ—πΠå §«“¡À≈“°À≈“¬¢Õß ◊ËÕ §«“¡‡À¡“– ¡¢Õß°“√„™â ◊ËÕ °“√ª√–™“ —¡æ—πΠå §«“¡‡æ’¬ßæÕ (®“° à«π°≈“ß) §«“¡ ¡Ë”‡ ¡Õ (®“° à«π°≈“ß) §«“¡‡æ’¬ßæÕ (¿“¬„π®—ßÀ«—¥) §«“¡ ¡Ë”‡ ¡Õ (¿“¬„π®—ßÀ«—¥) °“√π‘‡Σ»μ‘¥μ“¡ ª√–‡¡‘πº≈ °“√¡’ à«π√à«¡¢Õߪ√–™“™π„πæ◊ÈπΣ’Ë §«“¡§√Õ∫§≈ÿ¡°“√„Àâ∫√‘°“√ º≈°“√¥”‡π‘πß“π ¿“æ√«¡ √ŸªΣ’Ë3 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâªØ‘∫—μ‘ß“πμàÕ°‘®°√√¡μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πæ◊ÈπΣ’Ë√—∫º‘¥™Õ∫ μ“√“ßΣ’Ë6 §«“¡‡¢â“„®¢ÕߺŸâªØ‘∫—μ‘ß“π‡°’Ë¬«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß ª√–‡¥Á𧫓¡√Ÿâ §«“¡‡¢â“„® ®”π«π √âÕ¬≈– 1. À“°μ√«®§—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å·≈â«æ∫§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–°àÕπ ∂Ÿ° 1,378 91.0 ‡ªìπ¡–‡√Áß (CIN1 À√◊Õ LSIL) ‰¡à®”‡ªìπμâÕß√—°…“·μàμâÕß𗥄Àâ¡“μ√«®§—¥°√Õ߇æ◊ËÕ º‘¥ 136 9.0 μ‘¥μ“¡Õ¬à“ß„°≈♑¥ 2. À≠‘ßΣ’Ë‡ªìπ‚√§μ‘¥μàÕΣ“ß‡æ» —¡æ—πΠå ‰¥â·°à ÀŸ¥ÀßÕπ‰°à ´‘øî≈‘ ‰¡à§«√μ√«®§—¥°√Õß ∂Ÿ° 1,300 86.2 º‘¥ 208 13.8 3. À≈—ß®“°«—π ÿ¥Σ⓬¢Õß°“√¡’ª√–®”‡¥◊Õπ‰¡à “¡“√∂μ√«®§—¥°√Õ߉¥âΣ—πΣ’ ∂Ÿ° 1,092 72.8 º‘¥ 409 27.2 4. À“°μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ·≈â«æ∫§«“¡º‘¥ª√°μ‘¢Õ߇´≈≈å„π√–¬–°àÕπ‡ªìπ¡–‡√Áß ∂Ÿ° 698 48.8 μâÕ߉¥â√—∫°“√√—°…“¥â«¬°“√®’ȇ¬ÁπΣ—πΣ’ μâÕßμ‘¥μ“¡º≈·≈–μ√«®´È” º‘¥ 733 51.2 5. °“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ‡À¡“–°—∫À≠‘ß°≈ÿà¡Õ“¬ÿ 30-45 ªï Σ√“∫ 885 62.3 ‰¡àΣ√“∫ 535 37.7 6. À“°μ√«®§—¥°√Õß·≈⫉¡àæ∫§«“¡º‘¥ª√°μ‘μâÕß¡“√—∫°“√μ√«®´È”Σÿ° 5 ªï Σ√“∫ 956 63.6 ‰¡àΣ√“∫ 547 36.4 7. À≠‘ßΣ’Ëμ—¥¡¥≈Ÿ°∫“ß à«π·μଗߧߡ’ª“°¡¥≈Ÿ°‡À≈◊ÕÕ¬Ÿà§«√‡¢â“√—∫°“√μ√«®§—¥°√Õß Σ√“∫ 1,417 93.9 ‡™àπ‡¥’¬«°—∫À≠‘ßΣ’Ë‰¡à‰¥âμ—¥¡¥≈Ÿ° ‰¡àΣ√“∫ 92 6.1 550 Journal of Health Science 2012 Vol. 21 No. 3
14.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 √ŸªΣ’Ë4 §«“¡§‘¥‡ÀÁπ¢ÕߺŸâ∫√‘À“√μàÕπ‚¬∫“¬·≈–°‘®°√√¡°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 5 9 13 39 ♦ √ŸªΣ’Ë5 Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ®”·π°‡ªìπÕ—μ√“°“√ ‡¢â“√—∫∫√‘°“√ – ¡·≈–√“¬ªï (27%) °“√¥”‡π‘π°‘®°√√¡Σ’˺à“π¡“‡ªìπ°“√‡æ‘Ë¡¿“√– „π√–¥—∫ª“π°≈“ß (58%) ·≈–‡æ‘Ë¡¿“√–√–¥—∫¡“° (21%) ‡ªìπμâπ (√ŸªΣ’Ë 4) ºŸâ∫√‘À“√ à«π„À≠à‡§¬√—∫Σ√“∫π‚¬∫“¬°“√μ√«® §—¥°√Õß °≈à“«§◊Õ ∂“π欓∫“≈¿“¬„π®—ßÀ«—¥¢Õßμπ “¡“√∂„Àâ∫√‘°“√μ√«®§—¥°√Õ߉¥âΣ—Èß«‘Π’«’‰Õ‡Õ·≈– ·ªª ‡¡’¬√å (85%) ‚¥¬ºŸâμÕ∫·∫∫ Õ∫∂“¡ à«π„À≠à ‡ÀÁπ¥â«¬°—∫π‚¬∫“¬¥—ß°≈à“« (80%) ·μ৑¥«à“¡’ªí≠À“ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ·≈–Õÿª √√§‡°’ˬ«°—∫°“√¢“¥·§≈π∫ÿ§≈“°√ ‚¥¬ ‡©æ“–∫ÿ§≈“°√ºŸâ„Àâ∫√‘°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ §«“¡πà“‡™◊ËÕ∂◊Õ¢Õß°“√μ√«®§—¥°√Õߥ⫬«‘Π’«’‰Õ‡Õ ª√– ‘ΣΠ‘¿“æ¢Õß°“√∫—πΣ÷°·≈–√“¬ß“πº≈¢âÕ¡Ÿ≈ ·≈– ¿“√–Σ’Ë‡æ‘Ë¡¢÷Èπ¢ÕߺŸâªØ‘∫—μ‘ß“π ‡ªìπμâπ «‘®“√≥å °“√»÷°…“π’Èæ∫Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ°§àÕπ¢â“ß Ÿß Σ—Èß®“°°“√ ”√«®„π°≈ÿà¡ μ—«Õ¬à“ß (70%) ·≈–‡¡◊ËÕª√–¡“≥§à“°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√ÕߢÕß°≈ÿࡇªÑ“À¡“¬„π√–¥—∫ª√–‡Σ» (68%) ´÷Ë߇¡◊ËÕ‡ª√’¬∫‡Σ’¬∫°—∫¢âÕ¡Ÿ≈®“°·À≈àßÕ◊Ëπ ‰¥â·°à √“¬ß“πÕ—μ√“°“√‡¢â“√—∫∫√‘°“√„π√Õ∫ 5 ªï ≥ æ.». 2552 ®“°∞“π¢âÕ¡Ÿ≈¢Õß ∂“∫—π¡–‡√Áß·Ààß™“μ‘ °Áæ∫«à“¡’§à“ „°≈⇧’¬ß°—π §◊Õª√–¡“≥√âÕ¬≈– 70(5) πÕ°®“°π’Ȭ—ß„°≈â ‡§’¬ß°—∫°“√ ”√«® ∂“π°“√≥åÕπ“¡—¬‡®√‘≠æ—πΠÿå·≈– °“√‡¢â“∂÷ß∫√‘°“√¥â“πÕπ“¡—¬Σ—Ë«ª√–‡Σ» „πæ.». 2552 ‚¥¬ ”π—°ß“π ∂‘μ‘·Ààß™“μ‘√à«¡°—∫°√¡Õπ“¡—¬ ´÷Ëß π‚¬∫“¬ §«“¡‡¢â“„®π‚¬∫“¬·≈–«—μ∂ÿª√– ߧå ß∫ª√–¡“≥Σ’Ë‰¥â√—∫®—¥ √√‡æ’¬ßæÕ ¥â“π«‘™“°“√ ‡™àπ °“√®—¥Õ∫√¡°“√μ√«®§—¥°√Õß °“√ π—∫ πÿπ ®“° à«π°≈“ß °“√ª√– “πß“π‡æ◊ËÕ«“ß·ºπªØ‘∫—μ‘ß“π §«“¡æ√âÕ¡„Àâ∫√‘°“√ √–∫∫°“√ àßμàÕ àßμ√«®√—°…“ §«“¡√à«¡¡◊Õ¢ÕßÀπ૬ߓπΣ’Ë‡°’ˬ«¢âÕß °“√ªØ‘∫—μ‘ß“π ¿“¬„π®—ßÀ«—¥ °“√®—¥°“√¢âÕ¡Ÿ≈ °“√∫—πΣ÷° °“√„™â‚ª√·°√¡ ‡ªìπμâπ °“√√“¬ß“𠇙à𠧫“¡∂Ÿ°μâÕß §√∫∂â«π Σ—π‡«≈“ §ÿ≥¿“æ¢Õß √–∫∫¢âÕ¡Ÿ≈ §«“¡‡æ’¬ßæÕ¢Õß∫ÿ§≈“°√ °“√Õ∫√¡°“√μ√«®§—¥°√ÕßÕ¬à“ß ¡Ë”‡ ¡Õ °“√‡æ‘Ë¡¿“√–„Àâ°—∫∫ÿ§≈“°√ ∫ÿ§≈“°√ §«“¡®”‡ªìπΣ’ËμâÕß¡’°“√μ√«®§—¥°√Õß §«“¡À≈“°À≈“¬¢Õß°‘®°√√¡„Àâ∫√‘°“√ °‘®°√√¡°“√μ√«® §—¥°√Õß Õ—μ√“°“√‡¢â“√—∫“∫√‘°“√μ√«®§—¥°√Õß·μà≈–ªï Õ—μ√“°“√‡¢â“√—∫“∫√‘°“√μ√«®§—¥°√Õß – ¡ √âÕ¬≈– ♦ ♦ ♦ ♦ ♦ 7 65 2 16 29 æ.». 2548 æ.». 2549 æ.». 2550 æ.». 2551 æ.». 2552 ııÒ
15.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 · ¥ß„Àâ‡ÀÁπ«à“ ºŸâΣ’Ë¡’Õ“¬ÿ 30-59 ªï‡¢â“√—∫∫√‘°“√μ√«® §—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„π√Õ∫ 5 ªïΣ’Ëºà“π¡“§‘¥‡ªìπ ª√–¡“≥√âÕ¬≈– 60(10) √«¡Σ—Èßæ∫«à“ºŸâΣ’ËÕ“»—¬Õ¬Ÿà„π °√ÿ߇Σæ¡À“π§√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß„πÕ—μ√“μË” Σ’Ë ÿ¥ §◊Õ√âÕ¬≈– 44 ¢≥–Σ’Ë¿“§Õ◊Ëπ¡’°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß¡“°°«à“ §◊Õ √âÕ¬≈– 60-69 ”À√—∫°“√ »÷°…“π’ȺŸâ«‘®—¬‰¡à‰¥âΣ”°“√ ”√«®„πÀ≠‘ß°≈ÿࡇªÑ“À¡“¬ ®—ßÀ«—¥°√ÿ߇Σæoe ®÷ßÕ“®‡ªìπº≈„Àâæ∫Õ—μ√“°“√‡¢â“√—∫ ∫√‘°“√μ√«®§—¥°√Õß„π¿“æ√«¡√–¥—∫ª√–‡Σ» Ÿß°«à“ §«“¡‡ªìπ®√‘߉¥â º≈°“√ ”√«®®“°°“√»÷°…“π’È(8) ·≈–°“√√“¬ß“π ®“°∞“π¢âÕ¡Ÿ≈¢Õß ∂“∫—π¡–‡√Áß·Ààß™“μ‘(5) √«¡Σ—Èß°“√ ”√«®¢Õß ”π—°ß“π ∂‘μ‘·Ààß™“μ‘√à«¡°—∫°√¡ Õπ“¡—¬(10) „π√Õ∫ 5 ªï Σ’Ë¡’Õ—μ√“°“√‡¢â“√—∫∫√‘°“√Σ’Ë‡æ‘Ë¡ Ÿß¢÷Èππ’È Õ“® –ΣâÕπ«à“ °√–Σ√«ß “Π“√≥ ÿ¢·≈– Àπ૬ߓπΣ’Ë‡°’ˬ«¢âÕß‚¥¬‡©æ“–Õ¬à“߬‘Ëß ª ™.‰¥â ª√—∫ª√ÿß°“√®—¥∫√‘°“√‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°„À⥒¢÷ÈπÕ¬à“ß™—¥‡®π ºŸâ∫√‘À“√ ºŸâªØ‘∫—μ‘ß“π √«¡Σ—Èß°≈ÿࡇªÑ“À¡“¬„À⧫“¡ ”§—≠μàÕªí≠À“¡–‡√Áß ª“°¡¥≈Ÿ° ´÷Ëß àߺ≈„Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«® §—¥°√Õ߇æ‘Ë¡¢÷Èπ π—ÈπÀ¡“¬∂÷ß°‘®°√√¡Σ’Ë¥”‡π‘π°“√¿“¬ „μ₧√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬ «‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ æ.». 2548 - æ.». 2552 Σ”„Àâ Õ—μ√“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°„πª√–‡Σ»‰Σ¬ ‡æ‘Ë¡ Ÿß¢÷Èπ ‚¥¬‡©æ“–Õ¬à“߬‘Ëß„π™à«ß 1-2 ªïΣ’Ëºà“π¡“ (æ.». 2551-2552) ¥—ß· ¥ß„π√ŸªΣ’Ë 5 „π™à«ß‡«≈“¥—ß°≈à“«π’È ¡’°“√‡æ‘Ë¡√Ÿª·∫∫·≈–«‘Π’°“√√≥√ß§å ª√–™“ —¡æ—πΠå ®“°À≈“°À≈“¬™àÕßΣ“ß®“°Àπà«¬ß“π¿“§√—∞ πÕ°®“° π—Èπ¡’°“√ π—∫ πÿπ¥â“πß∫ª√–¡“≥‡æ◊ËÕ √â“ß·®ß®Ÿß„Àâ ·°à∫ÿ§≈“°√ºŸâ„Àâ∫√‘°“√°ÁÕ“®¡’º≈μàÕ°“√‡æ‘Ë¡¢÷Èπ¢Õß Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õ߇™àπ°—π ‚¥¬¢≥– Σ’ËΣ”°“√»÷°…“¡’Õ—μ√“§à“μÕ∫·Σπ°“√„Àâ∫√‘°“√μ√«® §—¥°√Õߥ⫬«‘Π’·ªª ‡¡’¬√å§√—Èß≈– 250 ∫“Σ ·≈–«‘Π’ «’‰Õ‡Õ§√—Èß≈– 70 ∫“Σ ´÷ËßÕ—μ√“¥—ß°≈à“«¬—߉¡à√«¡°“√ √—°…“‡¡◊ËÕæ∫§«“¡º‘¥ª√°μ‘ πÕ°®“°°“√‡æ‘Ë¡°“√√≥√ߧåª√–™“ —¡æ—πΠå·≈â« ªí®®—¬¥â“πºŸâ√—∫∫√‘°“√Σ’Ë‡°’ˬ«¢âÕß°—∫°“√√—∫√Ÿâ √«¡Σ—Èß Σ—»π§μ‘μàÕ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√Õß°Á¡’ §«“¡ ”§—≠μàÕ§«“¡ ”‡√Á®¢Õß‚§√ß°“√oe ‡π◊ËÕß®“° ‡ªìπªí®®—¬Σ’Ë°”Àπ¥°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß ¡–‡√Áߪ“°¡¥≈Ÿ° ·∫à߇ªìπ 2 ≈—°…≥–§◊Õªí®®—¬ à߇ √‘¡ ·≈–ªí®®—¬Σ’ˇªìπÕÿª √√§μàÕ°“√‡¢â“√—∫∫√‘°“√ ´÷Ë߇ªìπ ‰ªμ“¡·∫∫·ºπ§«“¡‡™◊ËÕ¥â“π ÿ¢¿“æ (health belief model)(11) Σ’Ë«à“∫ÿ§§≈Σ’Ë®–¡’æƒμ‘°√√¡À≈’°‡≈’ˬ߮“°‚√§ ®–μâÕß¡’§«“¡‡™◊ËÕ«à“μπ‡Õß¡’‚Õ°“ ‡ ’ˬßμàÕ°“√‡ªìπ‚√§ ‡™◊ËÕ«à“‚√§π—Èπ¡’§«“¡√ÿπ·√ß·≈–¡’º≈°√–Σ∫μàÕ°“√ ¥”‡π‘π™’«‘μ √«¡Σ—È߇™◊ËÕ«à“°“√ªØ‘∫—μ‘μ—«‡æ◊ËÕÀ≈’°‡≈’Ë¬ß μàÕ°“√‡ªìπ‚√§π—Èπ®–‡°‘¥º≈¥’„π°“√≈¥‚Õ°“ ‡ ’ˬßμàÕ °“√‡ªìπ‚√§À√◊ՙ૬≈¥§«“¡√ÿπ·√ߢÕß‚√§ ‚¥¬‰¡à §«√¡’Õÿª √√§¥â“π®‘μ«‘Σ¬“¡“‡°’ˬ«¢âÕß °“√»÷°…“¢Õß Lazcano-Ponce EC. ·≈–§≥–(12) æ∫«à“°“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√·≈–¡’§«“¡‡¢â“„®μàÕ «—μ∂ÿª√– ߧ尓√μ√«®§—¥°√Õß ‡ªìπªí®®—¬Σ’Ë π—∫ πÿπ „Àâ°≈ÿࡇªÑ“À¡“¬‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß πÕ°®“° π—Èπ°“√»÷°…“¢Õß Phipps E. ·≈–§≥–(13) ·≈– Boopongmanee ·≈–§≥–(14) æ∫«à“°“√Õ“»—¬Õ¬Ÿà„π ‡¢μ™π∫Σ °“√‰¥â√—∫¢âÕ¡Ÿ≈¢à“« “√ °“√ª√–°Õ∫Õ“™’æ ‡°…μ√°√√¡ §«“¡√Ÿâ·≈–Σ—»π§μ‘Σ’Ë¥’μàÕ°“√μ√«®§—¥ °√Õß·≈–‡®â“Àπâ“Σ’Ë ≈â«π‡ªìπªí®®—¬μàÕ°“√‡¢â“√—∫∫√‘°“√ μ√«®§—¥°√Õß ´÷Ëß Õ¥§≈âÕß°—∫º≈°“√»÷°…“„π§√—Èßπ’È à«πªí®®—¬Σ’ˇªìπÕÿª √√§À√◊Õ¢—¥¢«“ßμàÕ°“√‰ªμ√«® §—¥°√Õß ‡™à𠧫“¡√ŸâΣ’Ëº‘¥‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈– °“√μ√«®§—¥°√Õß Σ—»π§μ‘Σ’Ë‰¡à¥’μàÕ«‘Π’°“√μ√«®§—¥°√Õß º≈°“√»÷°…“¥—ß°≈à“«¡’§«“¡ Õ¥§≈âÕß°—∫ß“π«‘®—¬¢Õß Schulmeister L. ·≈–§≥–(15) Deschamps M. ·≈– §≥–(16) ·≈– Carter J. ·≈–§≥–(17) ´÷Ëß°“√»÷°…“‡À≈à“ π’È √ÿªº≈‰¥â«à“À≠‘ßΣ’Ë‰¡à¡’§«“¡√Ÿâ §«“¡‡¢â“„®‡°’ˬ«°—∫ ¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√μ√«®§—¥°√ÕßΣ’Ë¥’æÕ ®–‰¡à ‡°‘¥§«“¡μ√–Àπ—°μàÕ ÿ¢¿“æÀ√◊Õªí≠À“ ·≈–¡’‚Õ°“ ‡¢â“√—∫°“√μ√«®§—¥°√ÕßπâÕ¬°«à“À≠‘ßΣ’Ë¡’§«“¡√Ÿâ §«“¡ 552 Journal of Health Science 2012 Vol. 21 No. 3
16.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ‡¢â“„®Σ’Ë¥’ πÕ°®“°π—Èπ°“√»÷°…“§√—Èßπ’Èæ∫«à“ “‡Àμÿ¢Õß °“√‰¡à√—∫∫√‘°“√μ√«®§—¥°√Õ߇ªìπ‡æ√“–‰¡à¡’Õ“°“√º‘¥ ª√°μ‘ ‰¡à¡’‡«≈“μ√«® Õ“¬Σ’Ë®–μ√«® ‰¡à§‘¥«à“μπ‡Õß ‡ ’ˬ߇ªìπ¡–‡√Áß ·≈–°≈—«μ√«®æ∫‡ªìπ¡–‡√Áߪ“°¡¥≈Ÿ° Õ¥§≈âÕß°—∫¢âÕ§âπæ∫®“°ß“π«‘®—¬¢Õß Lee-Lin F. ·≈–§≥–(18) Steven D. ·≈–§≥–(19) Σ’Ëæ∫ “‡Àμÿ°“√ ‰¡à‡¢â“√—∫∫√‘°“√μ√«®§—¥°√ÕߢÕßÀ≠‘ß°≈ÿà¡μ—«Õ¬à“ß„π ≈—°…≥–‡¥’¬«°—π º≈°“√»÷°…“¥â“πªí®®—¬„π°≈ÿࡇªÑ“À¡“¬Σ’Ë°≈à“« ¢â“ßμâπ· ¥ß„Àâ‡ÀÁπ«à“ „π°“√¥”‡π‘π‚§√ß°“√oe ‡æ◊ËÕ ‡æ‘Ë¡Õ—μ√“°“√‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß¡–‡√Áߪ“° ¡¥≈Ÿ°π—Èπ ºŸâ„Àâ∫√‘°“√®–μâÕßæ‘®“√≥“·≈–Σ”§«“¡ ‡¢â“„®μàÕ≈—°…≥–‡©æ“–¢Õß°≈ÿࡇªÑ“À¡“¬ Σ’Ë¡’§«“¡ ·μ°μà“ß°—π„π·μà≈–æ◊ÈπΣ’Ë Σ—Èߥâ“π°“√√—∫√Ÿâ·≈–Σ—»π§μ‘ ¥â“πæƒμ‘°√√¡ ÿ¢¿“æ §«“¡¬“° ≈”∫“°„π°“√‡¥‘π Σ“ß‡æ◊ËÕ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß √«¡Σ—Èß«‘∂’°“√ ¥”‡π‘π™’«‘μ·≈–«—≤πΠ√√¡ ¥—ßπ—Èπ°“√æ—≤π“«‘Π’À√◊Õ °≈¬ÿΣΠå„π°“√ à߇ √‘¡ ª√–™“ —¡æ—πΠå·≈–°“√„Àâ ∫√‘°“√μâÕß¡’§«“¡®”‡æ“–·≈–·μ°μà“߉ªμ“¡≈—°…≥– ¢Õß·μà≈–æ◊ÈπΣ’Ë ´÷Ëߧ«√æ—≤π“«‘Π’À√◊Õ°≈¬ÿΣΠ凙‘ß√ÿ° ‚¥¬¡ÿà߇πâπ‡æ‘Ë¡°“√‡¢â“∂÷ߢâÕ¡Ÿ≈·≈–‡¢â“∂÷ß∫√‘°“√¢Õß ºŸâ√—∫∫√‘°“√ ¥â“πºŸâ„Àâ∫√‘°“√ æ∫ªí®®—¬Σ’Ë à߇ √‘¡„À₧√ß°“√oe ¡’·π«‚π⡪√– ∫§«“¡ ”‡√Á® ‰¥â·°à °“√‡ÀÁ𧫓¡ ”§—≠¢Õߪí≠À“¡–‡√Áߪ“°¡¥≈Ÿ°¢ÕߺŸâ∫√‘À“√·≈– ºŸâªØ‘∫—μ‘ß“π Õ’°Σ—Èßæ∫«à“ºŸâ∫√‘À“√·≈–ºŸâªØ‘∫—μ‘ß“π¡’ §«“¡‡ÀÁπ Õ¥§≈âÕß°—π«à“°“√μ√«®§—¥°√Õß¡–‡√Áߪ“ °¡¥≈Ÿ°‡ªìπ·π«Σ“ßΣ’Ë®”‡ªìπ„π°“√·°âªí≠À“ πÕ°®“° π—ÈπºŸâ∫√‘À“√¡’§«“¡‡¢â“„®π‚¬∫“¬·≈–«—μ∂ÿª√– ߧ尓√ μ√«®§—¥°√Õ߇ªìπÕ¬à“ߥ’ °“√„À⧫“¡ ”§—≠·≈–§«“¡ ‡¢â“„®‡À≈à“π’ȇªìπªí®®—¬æ◊Èπ∞“𠔧—≠¢Õß°“√æ—≤π“ °≈¬ÿΣΠå„π°“√¥”‡π‘πß“π·≈–Σ”„Àâ “¡“√∂¢—∫‡§≈◊ËÕπ π‚¬∫“¬√–¥—∫®—ßÀ«—¥‰¥â ·μຟâªØ‘∫—μ‘ß“π·≈–ºŸâ∫√‘À“√ à«πÀπ÷Ë߇ÀÁπ«à“®”π«π∫ÿ§≈“°√ ß∫ª√–¡“≥ ®”π«π °“√§«∫§ÿ¡§ÿ≥¿“扡à‡æ’¬ßæÕμàÕ°“√¥”‡π‘π‚§√ß°“√ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ¿“¬„π®—ßÀ«—¥ √«¡Σ—Èß∫“ß à«π‡ÀÁπ«à“√–∫∫¢âÕ¡Ÿ≈¬—ß ‰¡à¡’ª√– ‘ΣΠ‘¿“æ¡“°π—° ¥—ßπ—ÈπÀ“°‰¥â√—∫ª√—∫ª√ÿß‚¥¬ ‡æ‘Ë¡®”π«π°“√Õ∫√¡‡æ◊ËÕ‡æ‘Ë¡∫ÿ§≈“°√À√◊ÕÕ∫√¡øóôπøŸ ·°à∫ÿ§≈“°“√Σ’Ë‡§¬Õ∫√¡ ‡æ‘Ë¡°“√§«∫§ÿ¡§ÿ≥¿“æ°“√ μ√«®§—¥°√Õß®“° à«π°≈“ß ®–‡ªìπ°“√‡ √‘¡ªí®®—¬π” ‡¢â“¥â“π°“√„Àâ∫√‘°“√Σ’Ë‡Õ◊ÈÕμàÕ§«“¡ ”‡√Á®‚§√ß°“√ √«¡Σ—ÈßÀ“°¡’°“√ª√—∫ª√ÿß√–∫∫¢âÕ¡Ÿ≈‡æ◊ËÕ‡™◊ËÕ¡‚¬ß √–À«à“ß°“√μ√«®§—¥°√Õß°—∫°“√μ‘¥μ“¡ºŸâ¡’º≈‡´≈≈庑¥ ª√°μ‘„Àâ¡’ª√– ‘ΣΠ‘¿“æ ®–‡ªìπ°≈¬ÿΣΠåΣ’ËΣ”„Àâ¡’¢âÕ¡Ÿ≈Σ’Ë ∂Ÿ°μâÕß·≈–‡æ’¬ßæÕ„π°“√«“ß·ºπ°“√¥”‡π‘π‚§√ß°“√ „Àâª√– ∫§«“¡ ”‡√Á®μ“¡‡ªÑ“À¡“¬‰¥â¥’¬‘Ëߢ÷Èπ ´÷Ëß®“° §”·π–π”¢Õß International Agency for Research on Cancer: IARC(14) √–∫ÿ«à“°“√æ—≤π“°≈¬ÿΣΠå°“√ §«∫§ÿ¡·≈–ªÑÕß°—π¡–‡√Áߪ“°¡¥≈Ÿ°‡æ◊ËÕ„À⇰‘¥º≈º≈‘μ ·≈–º≈≈—æΠåÕ¬à“ß¡’ª√– ‘ΣΠ‘¿“æ®–μâÕߥ”‡π‘π°“√‡ªìπ √–∫∫·≈–¡’§«“¡æ√âÕ¡„πΣÿ°¢—ÈπμÕπ ‡√‘Ë¡μ—Èß·μà°“√ æ—≤π“Σ“ß¥â“ππ‚¬∫“¬ ªí®®—¬π”‡¢â“ ·≈–°√–∫«π°“√ À√◊Õ°‘®°√√¡¥”‡π‘πß“π ´÷Ëß¡’À≈“¬ß“π«‘®—¬Σ’ˇÀÁπ Õ¥§≈âÕßμ√ß°—π«à“ªí®®—¬¥â“π√–∫∫∫√‘°“√¡’º≈μàÕ°“√ ‡¢â“√—∫∫√‘°“√μ√«®§—¥°√Õß·≈–°“√‡¢â“√—∫°“√√—°…“(20-22) „π¢≥–‡¥’¬«°—π º≈°“√»÷°…“π’È°Á‰¥â· ¥ß„Àâ‡ÀÁπ«à“ ªí®®—¬æ◊Èπ∞“π‚¥¬‡©æ“–‚§√ß √â“ߢÕßÀπ૬∫√‘°“√¬—ß ‡ªìπªí≠À“·≈–Õÿª √√§„π°“√ªØ‘∫—μ‘ß“π ªí≠À“°“√ ¢“¥·§≈π∫ÿ§≈“°√·≈–°“√®—¥ √√ß∫ª√–¡“≥„π°“√ „Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ„π®—ßÀ«—¥Σ’Ë¡’°“√μ√«®§—¥°√Õß Σ—Èß Õß«‘Π’ ¥â«¬¢âÕ®”°—¥¥â“π°“√‡æ‘Ë¡∫ÿ§≈“°√ ‰¥â·°à §ÿ≥ ¡∫—μ‘¢ÕߺŸâ‡¢â“√—∫°“√Õ∫√¡Σ’ËμâÕ߇ªìπ欓∫“≈ «‘™“™’æ·≈–μâÕß√—∫°“√Õ∫√¡®“°Àπ૬ߓπΣ’Ë°√¡ Õπ“¡—¬¡Õ∫À¡“¬μ“¡°√Õ∫√–¬–‡«≈“·≈–¡“μ√∞“πΣ’Ë °”Àπ¥ ®÷ßΣ”„Àâ¡’®”π«π∫ÿ§≈“°√«’‰Õ‡Õ‰¡à‡æ’¬ßæÕμàÕ °“√„Àâ∫√‘°“√ à«π°“√®—¥ √√ß∫ª√–¡“≥μ“¡«‘Π’°“√ μ√«®§—¥°√Õß‚¥¬®à“¬„Àâ°—∫æ◊ÈπΣ’Ë·≈–∫ÿ§≈“°√ ºŸâ„Àâ ∫√‘°“√‡ÀÁπ«à“¡’§«“¡‡À≈◊ËÕ¡≈È” ‚¥¬«‘Π’«’‰Õ‡Õ‰¥â√—∫°“√ ®—¥ √√¥â“πß∫ª√–¡“≥πâÕ¬°«à“«‘Π’·ªª ‡¡’¬√å Σ”„Àâ ºŸâ∫√‘À“√ ∂“π欓∫“≈À√◊Õ·¡â·μຟâªØ‘∫—μ‘ß“π‰¡à¡’·√ß ııÛ
17.
The Evaluation of
Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005 - 2009 ®Ÿß„®Σ’Ë®–‡≈◊Õ°„™â«‘Π’«’‰Õ‡Õ„πæ◊ÈπΣ’Ë ∂÷ß·¡â®–‡ªìπ«‘Π’Σ’Ë √«¥‡√Á«·≈–ºŸâ√—∫∫√‘°“√‰¡àμâÕß°—ß«≈‡√◊ËÕß√Õº≈μ√«®(8) πÕ°®“°π—Èπæ∫«à“¬—ß¡’ºŸâ„Àâ∫√‘°“√∫“ß à«π‡¢â“„®º‘¥À√◊Õ ‰¡àΣ√“∫‡°’ˬ«°—∫«‘Π’·≈–¢—ÈπμÕπ°“√μ√«®§—¥°√Õߥ⫬ «‘Π’«’‰Õ‡Õ Σ—ÈßΣ’Ë‡ªìπ«‘Π’À≈—°πÕ°‡Àπ◊Õ®“°«‘Π’·ªª ‡¡’¬√å ´÷Ëß°”Àπ¥„Àâ„™â„π‚§√ß°“√§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ° 75 ®—ßÀ«—¥¥â«¬«‘Π’·ªª ‡¡’¬√å·≈–«’‰Õ ¥—ßπÈ—π∂÷ß·¡âæÈ◊πΣË’ π—Èπ Ê ‰¡à‰¥â„Àâ∫√‘°“√¥â«¬«‘Π’«’‰Õ‡Õ°Áμ“¡ ∫ÿ§≈“°√§«√ ‰¥â√—∫°“√Õ∫√¡§«“¡√Ÿâæ◊Èπ∞“πΣ—Èß Õß«‘Π’§«∫§Ÿà°—π ‡æ◊ËÕ Σ’Ë®–‰¥â ◊ËÕ “√°—∫ª√–™“™π‰¥â∂Ÿ°μâÕß ¢âÕ‡ πÕ·π–‡™‘ßπ‚¬∫“¬ 1) ‡æ‘Ë¡°“√ ◊ËÕ “√‡æ◊ËÕ à߇ √‘¡§«“¡√Ÿâ·≈–Σ—»π§μ‘ ‚¥¬¥”‡π‘π°“√Õ¬à“ßμàÕ‡π◊ËÕß·≈–ÕÕ°·∫∫„Àâ®”‡æ“– μàÕ≈—°…≥–¢Õß°≈ÿࡇªÑ“À¡“¬·≈–ª√–™“™πΣ—Ë«‰ª„π ·μà≈–æ◊ÈπΣ’Ë Õ“Σ‘ ‡¢μ™π∫Σ·≈–æ◊ÈπΣ’ËÀà“߉°≈ §«√ ª√–™“ —¡æ—πΠåºà“π ◊ËÕ™ÿ¡™πÀ√◊Õ ◊ËÕ™“«∫â“π√«¡°—∫ °√–μÿâπºà“π ◊ËÕÕ◊Ëπ Ê ‡¢μ‡¡◊Õß ·≈–°≈ÿࡇ©æ“– ‡™àπ ºŸâΣ’Ë Ÿ∫∫ÿÀ√’Ë §«√‡æ‘Ë¡°“√ª√–™“ —¡æ—πΠå‚¥¬‡πâπ°“√„™â ◊ËÕ “Π“√≥–·≈–°“√‡¢â“∂÷ß ∂“πΣ’ËΣ”ß“π ∂“πΣ’Ë “Π“√≥–Σ’Ë ”§—≠ ·≈–√≥√ߧå√à«¡°—∫Õߧå°√æ—≤π“ ‡Õ°™πÀ√◊ÕÀπ૬ߓπμà“ß Ê 2) ª√—∫√Ÿª·∫∫°“√„Àâ∫√‘°“√„π°≈ÿà¡Σ’Ë¡’§«“¡ §√Õ∫§≈ÿ¡μË” Õ“Σ‘ À≠‘ß¡ÿ ≈‘¡ §«√®—¥∫√‘°“√„π™à«ßΣ’Ë ‰¡à¢—¥·¬âßμàÕæ‘Π’°√√¡Σ“ß»“ π“ ‡™àπ ™à«ß∂◊Õ»’≈Õ¥ °“√ª√–°Õ∫æ‘Π’OE—®¬å √â“ߧ«“¡‡¢â“„®·≈–ª√—∫Σ—»π§μ‘ ‡°’ˬ«°—∫¡–‡√Áߪ“°¡¥≈Ÿ°·≈–°“√ªÑÕß°—π°—∫À—«Àπâ“ §√Õ∫§√—«·≈–ºŸâπ”»“ π“ ‡ªìπμâπ ºŸâΣ’ËÕ“»—¬Õ¬Ÿà„π‡¢μ ‡¡◊Õß §«√®—¥∫√‘°“√‡™‘ß√ÿ°„À⇢â“∂÷ß ∂“πΣ’ËΣ”ß“π ®—¥ ∫√‘°“√„π«—πÀ¬ÿ¥‡ “√å-Õ“Σ‘μ¬å ‡æ‘Ë¡§«“¡√à«¡¡◊Õ°—∫ ¿“§‡Õ°™π„À⺟â√—∫∫√‘°“√ “¡“√∂‡¢â“√—∫∫√‘°“√„π ∂“π ∫√‘°“√„°≈â∫â“π‰¥â‚¥¬‰¡à‡ ’¬§à“„™â®à“¬ à«πºŸâΣ’ËÕ“»—¬„π æ◊ÈπΣ’ËÀà“߉°≈ §«√®—¥∫√‘°“√„À⇢â“∂÷ß·≈–Õ“®‡ √‘¡·√ß °√–μÿâπ¥â«¬°“√ √â“ß·√ß®Ÿß„®„Àâμ√«®§—¥°√Õß¡–‡√Áß ª“°¡¥≈Ÿ°√à«¡°—∫°“√μ√«®§—¥°√Õß‚√§À√◊Õ°“√ à߇ √‘¡ ÿ¢¿“æÕ◊Ëπ Ê æ√âÕ¡°—π„π§√“«‡¥’¬« 3) ®—¥Õ∫√¡øóôπøŸ°“√μ√«®§—¥°√Õߥ⫬«‘Π’ ·ªª ‡¡’¬√å·≈–«’‰Õ‡Õ·°àºŸâªØ‘∫—μ‘ß“πÕ¬à“ßπâÕ¬ªï≈– 1 §√—Èß ¡’°“√§«∫§ÿ¡§ÿ≥¿“æ°“√Σ”ß“πÕ¬à“ß ¡Ë”‡ ¡Õ √«¡ Σ—Èßæ—≤𓂪√·°√¡§Õ¡æ‘«‡μÕ√å‡æ◊ËÕ°“√∫—πΣ÷°·≈– √“¬ß“π¢âÕ¡Ÿ≈ ‚¥¬ “¡“√∂‡™◊ËÕ¡‚¬ß√–∫∫°“√μ√«®§—¥ °√Õß°—∫√–∫∫§âπÀ“ºŸâ‰¡à‡§¬μ√«® √–∫∫μ‘¥μ“¡„π°≈ÿà¡ ºŸâ¡’º≈‡´≈≈庑¥ª√°μ‘‡æ◊ËÕ√—∫°“√√—°…“Õ¬à“ßμàÕ‡π◊ËÕ߉¥â ·≈–¡’°“√Õ∫√¡‡®â“Àπâ“Σ’Ë ‡ΩÑ“μ‘¥μ“¡À√◊Õ°”°—∫ §ÿ≥¿“æ¢Õß°“√∫—πΣ÷°¢âÕ¡Ÿ≈Õ¬à“ß ¡Ë”‡ ¡Õ 4) ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ·Ààß™“μ‘·≈– °√–Σ√«ß “Π“√≥ ÿ¢§«√¡’§«“¡™—¥‡®π„ππ‚¬∫“¬·≈– °“√°”Àπ¥‡ªÑ“À¡“¬√–¬–¬“«‡æ◊ËÕ≈¥§«“¡‡®Á∫ªÉ«¬ ·≈–°“√‡ ’¬™’«‘μ®“°¡–‡√Áߪ“°¡¥≈Ÿ° πÕ°®“°π—ÈπμâÕß ¡’§«“¡™—¥‡®π„π¥â“π«‘Π’μ√«®§—¥°√Õß °“√∫√‘À“√®—¥°“√ Õ’°Σ—Èߧ«√¡’°“√®—¥ √√ß∫ª√–¡“≥„Àâ‡À¡“– ¡‡æ◊ËÕ √â“ß·√ß®Ÿß„®·°àºŸâ∫√‘À“√ ∂“π欓∫“≈ Õ—π®– àߺ≈ μàÕª√– ‘ΣΠ‘¿“æ„π°“√Σ”ß“π¢ÕߺŸâªØ‘∫—μ‘ß“π à߇ √‘¡ ºŸâ„Àâ∫√‘°“√¡’§«“¡°â“«Àπâ“·≈–√—∫º‘¥™Õ∫ß“ππ’È„π √–¬–¬“« ·≈–‡æ◊ËÕ„À₧√ß°“√¡’§«“¡¬—Ë߬◊πμâÕß¡’°“√ ª√–™“ —¡æ—πΠå‡æ◊ËÕ √â“ߧ«“¡√Ÿâ·≈–Σ—»π§μ‘Σ’Ë¥’„π°≈ÿà¡ ºŸâ√—∫∫√‘°“√Õ¬à“ßμàÕ‡π◊ËÕß °‘μμ‘°√√¡ª√–°“» §≥–ºŸâ«‘®—¬¢Õ¢Õ∫§ÿ≥ ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ ·Ààß™“μ‘ ( ª ™.) ”À√—∫Σÿπ π—∫ πÿπß“π«‘®—¬§√—Èßπ’È Õ¬à“߉√°Áμ“¡Àπ૬ߓπΣ’Ë‡ªìπ·À≈àßΣÿπ¡‘‰¥â√—∫√Õ߇π◊ÈÕÀ“ ·≈–Õ“®¡’π‚¬∫“¬À√◊Õ§«“¡‡ÀÁπΣ’Ë‰¡à Õ¥§≈âÕß°—∫§«“¡ ‡ÀÁπ·≈–¢âÕ‡ πÕ·π–Σ’Ëª√“°Ø„π√“¬ß“ππ’È ¢Õ¢Õ∫§ÿ≥ °√¡Õπ“¡—¬ °√–Σ√«ß “Π“√≥ ÿ¢ Σ’Ë„À⧫“¡Õπÿ‡§√“–Àå ¥â“π¢âÕ¡Ÿ≈·≈–°“√ª√– “πß“π√–À«à“ߺŸâ„Àâ¢âÕ¡Ÿ≈„π à«π μà“ß Ê ¿“¬„π®—ßÀ«—¥μ—«Õ¬à“ß ¢Õ∫§ÿ≥ ”π—°ß“π ∂‘μ‘·Ààß ™“쑄𧫓¡Õπÿ‡§√“–Àå°”Àπ¥°≈ÿà¡μ—«Õ¬à“ß·≈–√–∫ÿæ◊ÈπΣ’Ë ‡ªÑ“À¡“¬ ¢Õ∫§ÿ≥‡§√◊Õ¢à“¬«‘®—¬§≈‘π‘° À ∂“∫—πΣ’Ë‡Õ◊ÈÕ‡øóôÕ ‚ª√·°√¡§Õ¡æ‘«‡μÕ√å„π°“√π”‡¢â“·≈–®—¥°“√¢âÕ¡Ÿ≈ß“π«‘®—¬ 554 Journal of Health Science 2012 Vol. 21 No. 3
18.
°“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥°√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å
·≈–«’‰Õ‡Õ „πª√–‡Σ»‰Σ¬ æ.». 2548 - 2552 ·≈–¢Õ¢Õ∫§ÿ≥𓬷æΣ¬å “Π“√≥ ÿ¢®—ßÀ«—¥ ºŸâª√– “πß“π ºŸâªØ‘∫—μ‘ß“π√–¥—∫®—ßÀ«—¥·≈–√–¥—∫æ◊ÈπΣ’ËΣ—Èß 12 ®—ßÀ«—¥ ‰¥â·°à ®—ßÀ«—¥‡™’¬ß„À¡à ·æ√à æ‘…≥ÿ‚≈° π§√æπ¡ √âÕ¬‡ÕÁ¥ π§√√“™ ’¡“ π§√ª∞¡ ‡æ™√∫ÿ√’ √–·°â« ™ÿ¡æ√ π§√»√’Π√√¡√“™ ·≈–®—ßÀ«—¥ ߢ≈“ Σ’ËÕ”π«¬§«“¡ –¥«°„π°“√≈ßæ◊ÈπΣ’Ë‡°Á∫√«∫√«¡¢âÕ¡Ÿ≈ß“π«‘®—¬ ·≈– ¢Õ∫§ÿ≥ºŸâ„Àâ¢âÕ¡Ÿ≈Σÿ°Σà“π¡“ ≥ Σ’Ëπ’ȥ⫬ «“√ “√«‘™“°“√ “Π“√≥ ÿ¢ Úııı ªïΣ’ËÚÒ ©∫—∫Σ’Ë Û ration Network: CRCN); 2010. 10. ”π—° ∂‘μ‘ —ߧ¡ ”π—°ß“π ∂‘μ‘·Ààß™“μ‘. √ÿªº≈Σ’Ë ”§—≠ °“√ ”√«®Õπ“¡—¬‡®√‘≠æ—πΠå æ.». 2552. °√ÿ߇Σæ¡À“π§√: ∫“ß°Õ°∫≈äÕ°; 2553. 11. Glanz K, Rimer BK, Lewis FM. Health behavior and health education: Theory, research and practice. San Fransisco: Wiley & Sons; 2002. 12. Lazcano-Ponce EC, Najera-Aguilar P, Buiatti E, Alonso-de-Ruiz P, Kuri P, Cantoral L, et al. The cer-vical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control 1997; Sep;8(5):698-704. 13. Phipps E, Cohen MH, Sorn R, Braitman LE. A pilot study of cancer knowledge and screening behaviors of Vietnamese and Cambodian women. Health Care Women Int 1999;20(2):195-207. 14. Boonpongmanee C, Jittanoon P. Predictors of Papani-colaou testing in working women in Bangkok, Thai-land. Cancer Nurs 2007;30(5):384-9. 15. Schulmeister L, Lifsey DS. Cervical cancer screening knowledge, behaviors, and beliefs of Vietnamese women. Oncol Nurs Forum 1999;26(5):879-87. 16. Deschamps M, Band PR, Hislop TG, Clarke HF, Smith JM, To Yee Ng V. Barriers to cervical cytology screen-ing in native women in British Columbia. Cancer De-tect Prev 1992;16(5-6):337-9. 17. Carter J, Park ER, Moadel A, Cleary SD, Morgan C. Cancer knowledge, attitudes, beliefs, and practices (KABP) of disadvantaged women in the South Bronx. J Cancer Educ 2002;17(3):142-9. 18. Lee-Lin F, Menon U, Mooney K. Cervical cancer be-liefs and pap test screening practices among Chinese American Immigarants. Oncology Nursing forum 2007;34(6):1203-09. 19. Steven D, Fitch M, Dhaliwal H, Kirk-Gardner R, Sevean P, Jamieson J, et al. Knowledge, attitudes, be-liefs, and practices regarding breast and cervical can-cer screening in selected ethnocultural groups in North-western Ontario. Oncol Nurs Forum 2004;31(2):305- 11. 20. Hernandez-Avila M, Lazcano-Ponce E, Lopez L, Alonso de Ruiz P, Rojas R. Evaluación del programa de detección oportuna de cáncer cervical in México. Gaceta Médica de México 1994;130:201-9. 21. Mutyaba T, Mmiro FA, Weiderpass E. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Med Educ 2006;1:6-13. 22. Udigwe GO. Knowledge, attitude and practice of cer-vical cancer screening (pap smear) among female nurses in Nnewi, South Eastern Nigeria. Niger J Clin Pract 2006;9(1):40-3. ‡Õ° “√Õâ“ßÕ‘ß 1. World Health Organization. Cervical cancer in devel-oping countries: report of a WHO consultation. Geneva: WHO; 2002. 2. Parkin DM, Whelan SL, Ferlay J, Teppo & Thomas DB. Cancer incidence in five continents Vol. VIII. IARC Scientific Publications [online]. 2003 [cited 2010 Aug 26]; Available from: http://www-dep.iarc.fr/. 3. Sankaranarayanan R. Cervical cancer in developing countries. Trans R Soc Trop Med Hyg 2002;96(6):580- 5. 4. National Cancer Institute. Cancer in Thailand Volume V 2001-2003. In: Khuhaprema T, Sriratanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Bangkok: Nation Cancer Institute; 2010. 5. National Cancer Institute. Cervical cancer screening 75 provinces Project (online). 2008 [cited 2010 July 12]; Available from: http://www.nci.go.th/ cxscreening/knowledge.html. 6. Sriamporn S, Khuhaprema T, Parkin M. Cervical can-cer screening in Thailand. J Med Screen 2006;13(Suppl 1):S39-S43. 7. International Health Policy Program Thailand (IHPP) and Health Intervention and Technology Assessment Program (HITAP). Research for development of an optimal policy strategy for prevention and control of cervical cancer in Thailand (online). 2008 [cited 2008 Oct 22]; Available from: http://www.hitap.net/ backoffice/news/pdf_news/2008-09-24_Final-Re-port- Cervica-Cancer.pdf. 8. Π’√– »‘√‘ ¡ÿ¥, √—°¡≥’ ∫ÿμ√™π, ‡™‘≠¢«—≠ ¿ÿ™¨ß§å, À—™™“ »√’ª≈—Ëß, π—¬π“ ª√–¥‘…∞å ‘ΣΠ‘°√, ≈’Ë≈’ Õ‘ß»√’ «à“ß, ·≈–§≥–. °“√ª√–‡¡‘πº≈ —¡ƒΣΠ‘Ï·≈–ªí®®—¬Σ’Ë¡’º≈μàÕ‚§√ß°“√μ√«®§—¥ °√Õß¡–‡√Áߪ“°¡¥≈Ÿ°¥â«¬«‘Π’·ªª ‡¡’¬√å (Pap Smear) ·≈– «’‰Õ‡Õ (Visual Inspection with Acetic Acid) „π ª√–‡Σ»‰Σ¬. ππΣ∫ÿ√’: ‚§√ß°“√ª√–‡¡‘π‡Σ§‚π‚≈¬’·≈– π‚¬∫“¬¥â“π ÿ¢¿“æ; 2553. 9. Online Medical Research Tools (OMERET) (com-puter program). ‡§√◊Õ¢à“¬°“√®—¥°“√¢âÕ¡Ÿ≈·≈–™’« ∂‘μ‘ ‡§√◊Õ¢à“¬«‘®—¬§≈’π‘° À ∂“∫—π (Clinical Research Collabo- ııı
Jetzt herunterladen